Category,Data Item Code,Data Item Name,SC,PHC/UPHC,CHC,SDH,DH,MC,AYUSH,Other Format,PVT,BHQ,DHQ
M1 [Ante Natal Care (ANC)],1.1,Total number of NEW Pregnant Women registered for ANC ,1.1.,1.1.,1.1.,1.1.,1.1.,1.1.,1.1.,1.1.,1.1.,,
,1.1.a,Out of total number of NEW Pregnant Women registered with age less than <15 years ,1.1.a,1.1.a,1.1.a,1.1.a,1.1.a,1.1.a,1.1.a,1.1.a,1.1.a,,
,1.1.b,Out of total number of NEW Pregnant Women registered with age 15-19 years ,1.1.b,1.1.b,1.1.b,1.1.b,1.1.b,1.1.b,1.1.b,1.1.b,1.1.b,,
,1.1.c,Out of total number of NEW Pregnant Women registered with age more than >19 to 49 years ,1.1.c,1.1.c,1.1.c,1.1.c,1.1.c,1.1.c,1.1.c,1.1.c,1.1.c,,
,1.1.d,Out of total number of NEW Pregnant Women registered with age more than >49 years ,1.1.d,1.1.d,1.1.d,1.1.d,1.1.d,1.1.d,1.1.d,1.1.d,1.1.d,,
,1.1.1,"Out of the total NEW ANC registered, number registered within 1st trimester (within 12 weeks) ",1.1.1.,1.1.1.,1.1.1.,1.1.1.,1.1.1.,1.1.1.,1.1.1.,1.1.1.,1.1.1.,,
,1.1.2,Total ANC footfall/cases (Old cases + New Registration) attended ,1.1.2,1.1.2,1.1.2,1.1.2.,1.1.2.,1.1.2,1.1.2,1.1.2,1.1.2.,,
,1.2.1,Number of PW given Td1 (Tetanus Diptheria dose 1) ,1.2.1.,1.2.1.,1.2.1.,1.2.1.,1.2.1.,1.2.1.,1.2.1.,1.2.1.,1.2.1.,,
,1.2.2,Number of PW given Td2 (Tetanus Diptheria dose 2) ,1.2.2.,1.2.2.,1.2.2.,1.2.2.,1.2.2.,1.2.2.,1.2.2.,1.2.2.,1.2.2.,,
,1.2.3,Number of PW given Td Booster (Tetanus Diptheria dose booster) ,1.2.3.,1.2.3.,1.2.3.,1.2.3.,1.2.3.,1.2.3.,1.2.3.,1.2.3.,1.2.3.,,
,1.2.4,Number of PW provided full course 180 Iron Folic Acid (IFA) tablets ,1.2.4.,1.2.4.,1.2.4.,1.2.4.,1.2.4.,1.2.4.,1.2.4.,1.2.4.,1.2.4.,,
,1.2.5,Number of PW provided full course 360 Calcium tablets ,1.2.5.,1.2.5.,1.2.5.,1.2.5.,1.2.5.,1.2.5.,1.2.5.,1.2.5.,1.2.5.,,
,1.2.6,Number of PW given one Albendazole tablet after 1st trimester ,1.2.6.,1.2.6.,1.2.6.,1.2.6.,1.2.6.,1.2.6.,1.2.6.,,1.2.6.,,
,1.2.7,Number of PW received 4 or more ANC check ups ,1.2.7.,1.2.7.,1.2.7.,1.2.7.,1.2.7.,1.2.7.,1.2.7.,1.2.6.,1.2.7.,,
,1.2.8,Number of PW given ANC Corticosteroids in Pre-Term Labour ,1.2.8.,1.2.8.,1.2.8.,1.2.8.,1.2.8.,1.2.8.,1.2.8.,,1.2.8.,,
,1.3.1,New cases of PW with hypertension detected ,1.3.1.,1.3.1.,1.3.1.,1.3.1.,1.3.1.,1.3.1.,1.3.1.,1.3.1.,1.3.1.,,
,1.3.2,Number of PW with hypertension managed at institution ,,1.3.2.,1.3.2.,1.3.2.,1.3.2.,1.3.2.,1.3.2.,1.3.2.,1.3.2.,,
,1.3.3.,Number of New Pre-Eclampsia/Eclampsia cases identified ,1.3.2.,1.3.3.,1.3.3.,1.3.3.,1.3.3.,1.3.3.,1.3.3.,,1.3.3.,,
,1.3.4,Number of Pre-Eclampsia/Eclampsia cases managed during ANC ,,1.3.4.,1.3.4.,1.3.4.,1.3.4.,1.3.4.,1.3.4.,,1.3.4.,,
,1.3.5,Number of Eclampsia cases managed during delivery ,,1.3.5.,1.3.5.,1.3.5.,1.3.5.,1.3.5.,1.3.5.,1.3.3.,1.3.5.,,
M1 [Ante Natal Care (ANC)],1.4.1.,Number of PW tested for Haemoglobin (Hb) 4 or more than 4 times for respective ANCs ,1.4.1.,1.4.1.,1.4.1.,1.4.1.,1.4.1.,1.4.1.,1.4.1.,1.4.1.,1.4.1.,,
,1.4.2.,Number of PW tested for Haemoglobin (Hb) ,1.4.2.,1.4.2.,1.4.2.,1.4.2.,1.4.2.,1.4.2.,1.4.2.,1.4.2.,1.4.2.,,
,1.4.3.,Number of PW having Hb level<11(7.1 to 10.9 g/dl) (Out of total tested cases) ,1.4.3.,1.4.3.,1.4.3.,1.4.3.,1.4.3.,1.4.3.,1.4.3.,1.4.3.,1.4.3.,,
,1.4.4.,Number of PW having Hb level<=7 g/dl (Out of total tested cases) ,1.4.4.,1.4.4.,1.4.4.,1.4.4.,1.4.4.,1.4.4.,1.4.4.,1.4.4.,1.4.4.,,
,1.4.5.,Number of PW treated for severe anaemia (Hb<=7g/dl) (including referred-in cases) ,,1.4.5.,1.4.5.,1.4.5.,1.4.5.,1.4.5.,1.4.5.,1.4.5.,1.4.5.,,
,1.5.1.,Number of PW tested for Blood Sugar using OGTT(Oral Glucose Tolerance Test) ,1.5.1.,1.5.1.,1.5.1.,1.5.1.,1.5.1.,1.5.1.,1.5.1.,1.5.1.,1.5.1.,,
,1.5.2.,Number of PW tested positive for GDM out of total OGTT(Oral Glucose Tolerance Test) conducted ,1.5.2.,1.5.2.,1.5.2.,1.5.2.,1.5.2.,1.5.2.,1.5.2.,1.5.2.,1.5.2.,,
,1.5.3.,Number of GDM positive PW managed with Insulin/Metformin out of total tested positive for GDM ,,1.5.3.,1.5.3.,1.5.3.,1.5.3.,1.5.3.,1.5.3.,,1.5.3.,,
,1.6.1.a,Number of pregnant/Direct-In-Labor (DIL) women screened/tested (with VDRL/RPR/TPHA/RDT/PoC) for Syphilis ,1.6.1.a,1.6.1.a,1.6.1.a,1.6.1.a,1.6.1.a,1.6.1.a,1.6.1.a,,1.6.1.a,,
,1.6.1.b,Number of pregnant/DIL women found Seropositive for Syphilis by VDRL/RPR/TPHA/RDT/PoC test ,1.6.1.b,1.6.1.b,1.6.1.b,1.6.1.b,1.6.1.b,1.6.1.b,1.6.1.b,,1.6.1.b,,
,1.6.1.c,Number of pregnant/DIL women found Syphilis-Seropositive and given treatment with injection Benzathine Penicillin (IM) ,1.6.1.c,1.6.1.c,1.6.1.c,1.6.1.c,1.6.1.c,1.6.1.c,1.6.1.c,,1.6.1.c,,
,1.6.1.d,Number of live births among Syphilis Seropositive Pregnant Women ,1.6.1.d,1.6.1.d,1.6.1.d,1.6.1.d,1.6.1.d,1.6.1.d,1.6.1.d,,1.6.1.d,,
,1.6.1.e,Number of babies born to Syphilis-Seropositive Pregnant Women tested positive/ clinically diagnosed for congenital Syphilis ,1.6.1.e,1.6.1.e,1.6.1.e,1.6.1.e,1.6.1.e,1.6.1.e,1.6.1.e,,1.6.1.e,,
,1.6.1.f,"Out of above, babies with congenital Syphilis received curative treatment ",1.6.1.f,1.6.1.f,1.6.1.f,1.6.1.f,1.6.1.f,1.6.1.f,1.6.1.f,,1.6.1.f,,
,1.7.1.,Number of Pregnant Women tested positive for Thyroid disorder ,,1.7.1.,1.7.1.,1.7.1.,1.7.1.,1.7.1.,1.7.1.,,1.7.1.,,
,1.7.2.,Number of Pregnant Women treated for thyroid disorder ,,1.7.2.,1.7.2.,1.7.2.,1.7.2.,1.7.2.,1.7.2.,,1.7.2.,,
,1.8.1.,Number of Pregnant Women screened for TB ,1.7.1.,1.8.1.,1.8.1.,1.8.1.,1.8.1.,1.8.1.,1.8.1.,,1.8.1.,,
,1.8.2.,Number of Pregnant Women identified with Presumptive TB symptoms ,1.7.2.,1.8.2.,1.8.2.,1.8.2.,1.8.2.,1.8.2.,1.8.2.,,1.8.2.,,
M1 [Ante Natal Care (ANC)],1.8.3.,Number of Pregnant Women referred out of those identified with Presumptive TB symptoms ,1.7.3.,1.8.3.,1.8.3.,1.8.3.,1.8.3.,1.8.3.,1.8.3.,,1.8.3.,,
,1.9.1.,Total High Risk Pregnancy (HRP) Intrapartum including following: ,1.8.1.,1.9.1.,1.9.1.,1.9.1.,1.9.1.,1.9.1.,1.9.1.,,1.9.1.,,
,1.9.1.a.,Number of Pregnant Women only with Post-Partum Haemorrhage(Immediately after delivery) in the facility ,1.8.1.a.,1.9.1.a.,1.9.1.a.,1.9.1.a.,1.9.1.a.,1.9.1.a.,1.9.1.a.,,1.9.1.a.,,
,1.9.1.b.,Number of Pregnant Women only with Sepsis in the facility ,1.8.1.b.,1.9.1.b.,1.9.1.b.,1.9.1.b.,1.9.1.b.,1.9.1.b.,1.9.1.b.,,1.9.1.b.,,
,1.9.1.c.,Number of Pregnant Women identified only with Eclampsia in the facility ,1.8.1.c.,1.9.1.c.,1.9.1.c.,1.9.1.c.,1.9.1.c.,1.9.1.c.,1.9.1.c.,,1.9.1.c.,,
,1.9.1.d.,Number of Pregnant Women identified only with obstructed labour in the facility ,1.8.1.d.,1.9.1.d.,1.9.1.d.,1.9.1.d.,1.9.1.d.,1.9.1.d.,1.9.1.d.,,1.9.1.d.,,
,1.9.1.e.,Number of Pregnant Women identified with more than 1 complication listed above ,1.8.1.e.,1.9.1.e.,1.9.1.e.,1.9.1.e.,1.9.1.e.,1.9.1.e.,1.9.1.e.,,1.9.1.e.,,
,1.9.2.,Total High Risk Pregnancy (HRP) Antepartum (Only New Cases are to be reported) ,1.8.2.,1.9.2.,1.9.2.,1.9.2.,1.9.2.,1.9.2.,1.9.2.,,1.9.2.,,
,1.9.3.,Total no. of highrisk ANC cases referred to Higher/ any other facility (Referred out) ,1.8.3.,1.9.3.,1.9.3.,1.9.3.,1.9.3.,1.9.3.,1.9.3.,,1.9.3.,,
,1.9.3.a.,Total no. of Intrapartum/PNC High Risk Pregnancy cases referred to Higher/ any other facility (Referred out) ,1.8.3.a,1.9.3.a,1.9.3.a.,1.9.3.a.,1.9.3.a.,1.9.3.a,1.9.3.a,,1.9.3.a.,,
,1.9.4.,Total no. of highrisk ANC cases referred in to the facility (Referred in) ,,1.9.4,1.9.4.,1.9.4.,1.9.4.,1.9.4.,1.9.4,,1.9.4.,,
,1.9.4.a.,Total no. of Intrapartum/PNC High Risk Pregnancy cases attended or referred into the facility (Referred in) ,,1.9.4.a,1.9.4.a,1.9.4.a.,1.9.4.a.,1.9.4.a,1.9.4.a,,1.9.4.a.,,
M2 [Deliveries],2.1.1.a,Number of Home Deliveries attended by Skill Birth Attendant(SBA) (Doctor/Nurse/ANM) ,2.1.1.a,2.1.1.a,2.1.1.a,2.1.1.a,2.1.1.a,,2.1.1.a,,2.1.1.a,,
,2.1.1.b,Number of Home Deliveries attended by Non SBA ,2.1.1.b,2.1.1.b,2.1.1.b,2.1.1.b,2.1.1.b,,2.1.1.b,,2.1.1.b,,
,2.1.2.,Number of PW given Tablet Misoprostol during home delivery ,2.1.2.,2.1.2.,2.1.2.,2.1.2.,2.1.2.,,2.1.2.,,2.1.2.,,
,2.2.,Number of Institutional Deliveries conducted (Including C-Sections) ,2.2.,2.2.,2.2.,2.2.,2.2.,2.1.,2.2.,2.1.,2.2.,,
,2.2.1.,"Out of total institutional deliveries(excluding C-section), number of women stayed for 48 hours or more after delivery ",2.2.1.,2.2.1.,2.2.1.,2.2.1.,2.2.1.,2.1.1.,2.2.1.,,2.2.1.,,
M2 [Deliveries],2.2.2.,"Out of total Institutional deliveries, number of Institutional Deliveries (Excluding C-Sections) conducted at night (8 PM- 8 AM) ",2.2.2.,2.2.2,2.2.2,2.2.2,2.2.2.,2.1.2.,2.2.2,,2.2.2,,
,2.2.3.,"Out of total Institutional deliveries, number of institutional deliveries conducted at Midwifery Led Care Unit (MLCU) ",,,2.2.3.,2.2.3.,2.2.3.,2.1.3.,,,2.2.3.,,
,2.3.1.,"Out of total number of delivery, PW with age less than <15 years ",2.3.1.,2.3.1.,2.3.1.,2.3.1.,2.3.1.,2.2.1.,2.3.1.,2.2.1.,2.3.1.,,
,2.3.2.,"Out of total number of delivery, PW with age 15-19 years ",2.3.2.,2.3.2.,2.3.2.,2.3.2.,2.3.2.,2.2.2.,2.3.2.,2.2.2.,2.3.2.,,
,2.3.3.,"Out of total number of delivery, PW with age more than >19-49 years ",2.3.3.,2.3.3.,2.3.3.,2.3.3.,2.3.3.,2.2.3.,2.3.3.,2.2.3.,2.3.3.,,
,2.3.4.,"Out of total number of delivery, PW with age more than > 49 years ",2.3.4.,2.3.4.,2.3.4.,2.3.4.,2.3.4.,2.2.4.,2.3.4.,2.2.4.,2.3.4.,,
,2.4.,Number of newborns received 6/7 HBNC visits after Delivery (Home+ Institutional) ,2.4.,2.4.,2.4.,2.4.,2.4.,,2.4.,,2.4.,,
,2.5.,No. of identified Sick new-borns referred by ASHA to facility under HBNC Programme ,2.5.,2.5.,2.5.,2.5.,2.5.,,2.5.,,2.5.,,
,2.6.,Total number of Children received all scheduled 5 Home visits under HBYC ,2.6.,2.6.,2.6.,2.6.,2.6.,,2.6.,,2.6.,,
M3 [Number of Caesarean (C-Section) deliveries],3.1.,Total number of C -Section deliveries performed ,,3.1.,3.1.,3.1.,3.1.,3.1.,3.1.,3.1.,3.1.,,
,3.1.1.,"Out of total C-sections, number performed at night (8 PM- 8 AM) ",,3.1.1.,3.1.1.,3.1.1.,3.1.1.,3.1.1,3.1.1.,3.1.1,3.1.1.,,
,3.1.2.,"Out of total C-section, number of women stayed for 72 hours or more after delivery ",,3.1.2.,3.1.2.,3.1.2.,3.1.2.,3.1.2,3.1.2.,,3.1.2.,,
M4 [Pregnancy outcome & details of new-born],4.1.1.a,Live Birth - Male ,3.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,4.1.1.a,,
,4.1.1.b,Live Birth - Female ,3.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,4.1.1.b,,
,4.1.2.,Number of Pre-term newborns ( < 37 weeks of pregnancy) ,3.1.2.,4.1.2.,4.1.2.,4.1.2.,4.1.2.,4.1.2.,4.1.2.,4.1.2.,4.1.2.,,
,4.1.3.a,Fresh Stillbirth - Intrapartum Stillbirth (28 weeks & above) ,3.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,4.1.3.a,,
,4.1.3.b,Mascerated Stillbirth – Antepartum Stillbirth (28 weeks &above) ,3.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,4.1.3.b,,
,4.1.3.c,Foetal Death (24–27 completed weeks) ,3.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,4.1.3.c,,
,4.2.,Abortion (spontaneous) ,3.2.,4.2.,4.2.,4.2.,4.2.,4.2.,4.2.,4.2.,4.2.,,
,4.3.1.a,Surgical MTPs upto 12 weeks of pregnancy ,,4.3.1.a,4.3.1.a,4.3.1.a,4.3.1.a,4.3.1.a,4.3.1.a,4.3.1.a,4.3.1.a,,
,4.3.1.b,MTP more than 12 weeks of pregnancy ,,4.3.1.b,4.3.1.b,4.3.1.b,4.3.1.b,4.3.1.b,4.3.1.b,4.3.1.b,4.3.1.b,,
M4 [Pregnancy outcome & details of new-born],4.3.1.c,MTPs completed through Medical methods of abortion (MMA) ,,4.3.1.c,4.3.1.c,4.3.1.c,4.3.1.c,4.3.1.c,4.3.1.c,4.3.1.c,4.3.1.c,,
,4.3.2.a,Total Post-abortion/MTP Complications Identified ,3.3.1,4.3.2.a,4.3.2.a,4.3.2.a,4.3.2.a,4.3.2.a,4.3.2.a,,4.3.2.a,,
,4.3.2.b.,Post-abortion/MTP complications identified (where abortions were carried out in facilities other than public and accredited private health facilities) ,3.3.2.,4.3.2.b.,4.3.2.b.,4.3.2.b.,4.3.2.b.,4.3.2.b.,4.3.2.b.,,4.3.2.b.,,
,4.3.2.c.,Post-abortion/MTP Complications treated ,,4.3.2.c.,4.3.2.c.,4.3.2.c.,4.3.2.c.,4.3.2.c.,4.3.2.c.,,4.3.2.c.,,
,4.3.3.,Number of women provided with Post-abortion/ MTP contraception ,,4.3.3.,4.3.3.,4.3.3.,4.3.3.,4.3.3.,4.3.3.,,4.3.3.,,
,4.4.1.,Number of Newborns weighed at birth ,3.4.1.,4.4.1.,4.4.1.,4.4.1.,4.4.1.,4.4.1.,4.4.1.,4.4.1.,4.4.1.,,
,4.4.2.,Number of Newborns having weight less than 2500 gms ,3.4.2.,4.4.2.,4.4.2.,4.4.2.,4.4.2.,4.4.2.,4.4.2.,4.4.2.,4.4.2.,,
,4.4.2.a,"Out of the above, number of Newborns having weight less than 1800 gms ",3.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,4.4.2.a,,
,4.4.3.,Number of Newborns breast fed within 1 hour of birth  ,3.4.3.,4.4.3.,4.4.3.,4.4.3.,4.4.3.,4.4.3.,4.4.3.,4.4.3.,4.4.3.,,
,4.4.4.,No. of Newborns discharged from the facility were exclusively breastfed till discharge ,3.4.4.,4.4.4.,4.4.4.,4.4.4.,4.4.4.,4.4.4.,4.4.4.,4.4.4.,4.4.4.,,
,4.4.5,Number of Newborns received Donor Human Milk (DHM) in the facility ,,,,,4.4.5.,4.4.5,,,,,
,4.5.1.,"Number of Newborns screened for defects at birth (as per Comprehensive Newborn Screening, RBSK) ",3.5.1,4.5.1,4.5.1.,4.5.1.,4.5.1,4.5.1.,4.5.1,4.5.1.,4.5.1.,,
,4.5.1.a,"Number of Newborns identified with visible birth defects (including Neural tube defect, Down’s Syndrome, Cleft Lip & Palate, Club foot and Developmental dysplasia of the hip) ",3.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,4.5.1.a,,
,4.5.2.,Number of children (6 Weeks to 6 years) screened by RBSK mobile health teams at Anganwadi center,,,,,,,,,,1.1.,
,4.5.2.a,Number of children (6 years to 18 years) screened by RBSK mobile health teams at Govt and Govt aided schools,,,,,,,,,,1.1.a,
,4.5.3.,Number of SNCU discharged babies screened in DEIC,,,,4.5.2.,4.5.2.,4.5.2.,,,4.5.2.,,
,4.5.4.a.1.,Number of children identified with Disease by RBSK Mobile Health teams,,,,,,,,,,1.2.1.a,
M4 [Pregnancy outcome & details of new-born],4.5.4.b.1.,Number of children identified with Deficiency by RBSK Mobile Health teams,,,,,,,,,,1.2.2.a,
,4.5.4.c.1.,Number of children identified with Developmental delay by RBSK Mobile Health teams,,,,,,,,,,1.2.3.a,
,4.5.4.d.1.,Number of children (0 - 18 years) identified with selected birth defect by RBSK Mobile Health teams,,,,,,,,,,1.2.4.a,
,4.5.5.,"Number of children till age 18 years (affected with selected health conditions) managed for 4 Ds (Disease, Deficiency, Developmental Delay & Defect)",,4.5.2,4.5.2.,4.5.3.,4.5.3.,4.5.3.,4.5.2,,4.5.3.,,
,4.5.6.,Number of children till age 18 years (affected with selected health conditions) managed by Intervention - Surgical ,,,,4.5.4.,4.5.4,4.5.4.,,,4.5.4.,,
,4.5.7.,Number of children till age 18 years managed at DEIC (District Early Intervention Centre) ,,,,,4.5.5.,4.5.5.,,,,,
M5 [Anaemia Mukt Bharat],5.1.1.,"Number of women of reproductive age (WRA) 20-49 years (non-pregnant, non-lactating), provided 4 Red Iron and folic acid (IFA) tablets in a month ",4.1.1.,5.1.1.,5.1.1.,5.1.1.,5.1.1.,,5.1.1.,,5.1.1.,,
,5.1.2.,Number of children (6-59 months old) provided 8-10 doses (1ml) of IFA syrup (Bi weekly) ,4.1.2.,5.1.2.,5.1.2.,5.1.2.,5.1.2.,,5.1.2.,,5.1.2.,,
,5.1.3.a,Number of out of school children (5 -9 years) given 4-5 IFA Pink tablets at Anganwadi Centres ,4.1.3.a,5.1.3.a,5.1.3.a,5.1.3.a,5.1.3.a,,5.1.3.a,,5.1.3.a,,
,5.1.3.b,Number of in-school children (5 - 9 years) provided 4-5 IFA Pink tablets in schools,,,,,,,,,,2.1.1.a,
,5.2.1.a,Number of in-school Children (5-9 years) having anaemia (Hb 8.1-11.4 g/dL (deciliter)),,,,,,,,,,2.2.1.a,
,5.2.1.b,Number of in-school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dL (deciliter)),,,,,,,,,,2.2.1.b,
,5.2.1.c,Number of out of school adolescent girls (10-19 years) having anaemia (Hb 8.1-11.9 g/dl),4.2.1.a,5.2.1.a,5.2.1.a,5.2.1.a,5.2.1.a,,5.2.1.a,,5.2.1.a,,
,5.2.1.d.i,Number of boys 10-11 years having anaemia (Hb 8.1-11.4 g/dL (deciliter)),,,,,,,,,,2.2.1.c.i,
M5 [Anaemia Mukt Bharat],5.2.1.d.ii,Number of boys 12-14 years having anaemia (Hb 8.1-11.9 g/dL (deciliter)),,,,,,,,,,2.2.1.c.ii,
,5.2.1.d.iii,Number of boys 15-19 years having anaemia (Hb 8.1-12.9 g/dL (deciliter)),,,,,,,,,,2.2.1.c.iii,
,5.2.1.e.,Number of lactating mothers (of 0-6 months old child) having anaemia (Hb 8.1-11.9 g/dl),4.2.1.b,5.2.1.b,5.2.1.b,5.2.1.b,5.2.1.b,,5.2.1.b,,5.2.1.b,,
,5.2.1.f.,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having anaemia (Hb 8.1-11.9 g/dl) ",4.2.1.c,5.2.1.c,5.2.1.c,5.2.1.c,5.2.1.c,,5.2.1.c,,5.2.1.c,,
,5.2.2.a,Number of in-school Children (5-9 years) having severe anaemia (Hb <8 g/dL (deciliter)),,,,,,,,,,2.2.2.a,
,5.2.2.b,Number of in-school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dL (deciliter)),,,,,,,,,,2.2.2.b,
,5.2.2.c,Number of out of school adolescent girls (10-19 years) having severe anaemia (Hb <8 g/dl),4.2.2.a,5.2.2.a,5.2.2.a,5.2.2.a,5.2.2.a,,5.2.2.a,,5.2.2.a,,
,5.2.2.d,Number of in-school adolescent boys (10-19 years) having severe anaemia (Hb <8 g/dL (deciliter)),,,,,,,,,,2.2.2.c,
,5.2.2.e,Number of lactating mothers (of 0-6 months old child) having severe anaemia (Hb <8 g/dl),4.2.2.b,5.2.2.b,5.2.2.b,5.2.2.b,5.2.2.b,,5.2.2.b,,5.2.2.b,,
,5.2.2.f,"Number of women of reproductive age (non-pregnant, non-lactating) (20-49 years) having severe anaemia (Hb <8 g/dl)",4.2.2.c,5.2.2.c,5.2.2.c,5.2.2.c,5.2.2.c,,5.2.2.c,,5.2.2.c,,
,5.2.3.a,Number of anaemic in-school Children (5-9 years) put on treatment ,4.2.3.a,5.2.3.a,5.2.3.a,5.2.3.a,5.2.3.a,,5.2.3.a,,5.2.3.a,,
,5.2.3.b,Number of anaemic in-school adolescent girls (10-19 years) put on treatment,4.2.3.b,5.2.3.b,5.2.3.b,5.2.3.b,5.2.3.b,,5.2.3.b,,5.2.3.b,,
,5.2.3.c,Number of anaemic out of school adolescent girls (10-19 years) put on treatment,4.2.3.c,5.2.3.c,5.2.3.c,5.2.3.c,5.2.3.c,,5.2.3.c,,5.2.3.c,,
,5.2.3.d,Number of anaemic in-school adolescent boys (10-19 years) put on treatment ,4.2.3.d,5.2.3.d,5.2.3.d,5.2.3.d,5.2.3.d,,5.2.3.d,,5.2.3.d,,
,5.2.3.e,Number of anaemic lactating mothers (of 0-6 months old child) put on treatment ,4.2.3.e,5.2.3.e,5.2.3.e,5.2.3.e,5.2.3.e,,5.2.3.e,,5.2.3.e,,
,5.2.3.f,"Number of anaemic women of reproductive age (non-pregnant, non-lactating) (20-49 years) put on treatment ",4.2.3.f,5.2.3.f,5.2.3.f,5.2.3.f,5.2.3.f,,5.2.3.f,,5.2.3.f,,
,5.2.4.a,Number of lactating mothers (of 0-6 months old child) diagnosed with severe anaemia and put on treatment ,,,5.2.4.a,5.2.4.a,5.2.4.a,5.1.a,,,5.2.4.a,,
M6 [Post Natal Care (PNC)],6.1.,"In case of home delivery, number of women receiving 1st Postpartum checkups within 48 hours ",5.1.,6.1.,6.1.,6.1.,6.1.,,6.1.,,6.1.,,
,6.2.,Number of women receiving Postpartum checkup between 48 hours and 14 days after Institutional delivery ,5.2.,6.2.,6.2.,6.2.,6.2.,6.1.,6.2.,,6.2.,,
,6.3.,Number of mothers provided full course of 180 IFA tablets after delivery ,5.3.,6.3.,6.3.,6.3.,6.3.,6.2.,6.3.,,6.3.,,
,6.4.,Number of mothers provided full course 360 Calcium tablets after delivery ,5.4.,6.4.,6.4.,6.4.,6.4.,6.3.,6.4.,,6.4.,,
,6.5.,Total No of High Risk Mothers identified during Post Natal Period ,5.5.,6.5.,6.5.,6.5.,6.5.,6.4.,6.5.,,6.5.,,
,6.6.,Out of above identified number of High Risk Mothers managed (including referred in cases) ,5.6.,6.6.,6.6.,6.6.,6.6.,6.5.,6.6.,,6.6.,,
M7 [Sexually Transmitted Infections/Reproductive Tract Infections (STI/RTI) Cases],7.1.1.,Number of males assessed for STI/RTI ,6.1.1.,7.1.1.,7.1.1.,7.1.1.,7.1.1.,7.1.1.,7.1.1.,,7.1.1.,,
,7.1.1.a,"Out of the above, number of males diagnosed with STI/RTI ",6.1.1.a,7.1.1.a,7.1.1.a,7.1.1.a,7.1.1.a,7.1.1.a,7.1.1.a,,7.1.1.a,,
,7.1.1.b,"Out of the above, number of males treated for STI/RTI ",6.1.1.b,7.1.1.b,7.1.1.b,7.1.1.b,7.1.1.b,7.1.1.b,7.1.1.b,,7.1.1.b,,
,7.1.2.,Number of females (all females) assessed for STI/RTI ,6.1.2.,7.1.2.,7.1.2.,7.1.2.,7.1.2.,7.1.2.,7.1.2.,,7.1.2.,,
,7.1.2.a,"Out of the above, number of females (all females) diagnosed with STI/RTI ",6.1.2.a,7.1.2.a,7.1.2.a,7.1.2.a,7.1.2.a,7.1.2.a,7.1.2.a,,7.1.2.a,,
,7.1.2.b,"Out of the above, number of females (all females) treated for STI/RTI ",6.1.2.b,7.1.2.b,7.1.2.b,7.1.2.b,7.1.2.b,7.1.2.b,7.1.2.b,,7.1.2.b,,
,7.1.3.,Number of H/TG assessed for STI/RTI ,6.1.3.,7.1.3.,7.1.3.,7.1.3.,7.1.3.,7.1.3.,7.1.3.,,7.1.3.,,
,7.1.3.a,"Out of the above, number of H/TG people diagnosed with STI/RTI ",6.1.3.a,7.1.3.a,7.1.3.a,7.1.3.a,7.1.3.a,7.1.3.a,7.1.3.a,,7.1.3.a,,
,7.1.3.b,"Out of the above, number of H/TG people treated for STI/RTI ",6.1.3.b,7.1.3.b,7.1.3.b,7.1.3.b,7.1.3.b,7.1.3.b,7.1.3.b,,7.1.3.b,,
M8 [Family Planning],8.1.1.,Number of Non Scalpel Vasectomy (NSV) / Conventional Vasectomy conducted ,,8.1.1.,8.1.1.,8.1.1.,8.1.1.,8.1.1.,8.1.1.,5.1.1.,8.1.1.,,
,8.2.1.,Number of Laparoscopic sterilizations (excluding post-abortion) conducted ,,8.2.1.,8.2.1.,8.2.1.,8.2.1.,8.2.1.,8.2.1.,5.2.1.,8.2.1.,,
,8.2.2.,Number of Interval sterilizations (Mini-lap/Conventional) (other than post-partum and post abortion) conducted ,,8.2.2.,8.2.2.,8.2.2.,8.2.2.,8.2.2.,8.2.2.,5.2.2.,8.2.2.,,
,8.2.3.,Number of Postpartum sterilizations (within 7 days of delivery by minilap or concurrent with caesarean section) conducted ,,8.2.3.,8.2.3.,8.2.3.,8.2.3.,8.2.3.,8.2.3.,5.2.3.,8.2.3.,,
,8.2.4.,Number of Post-abortion sterilizations (within 7 days of spontaneous or surgical abortion) conducted ,,8.2.4.,8.2.4.,8.2.4.,8.2.4.,8.2.4.,8.2.4.,5.2.4.,8.2.4.,,
M8 [Family Planning],8.3.,Number of Interval IUCD Insertions (excluding PPIUCD and PAIUCD) ,7.1.,8.3.,8.3.,8.3.,8.3.,8.3.,8.3.,5.3.,8.3.,,
,8.4.,Number of Postpartum (within 48 hours of delivery) IUCD insertions ,7.2.,8.4.,8.4.,8.4.,8.4.,8.4.,8.4.,5.4.,8.4.,,
,8.5.,Number of Post-abortion (within 12 days of spontaneous or surgical abortion) IUCD insertions ,,8.5.,8.5.,8.5.,8.5.,8.5.,8.5.,,8.5.,,
,8.6.,Number of IUCD Removals ,7.3.,8.6.,8.6.,8.6.,8.6.,8.6.,8.6.,,8.6.,,
,8.7.,Number of complications following IUCD Insertion ,7.4.,8.7.,8.7.,8.7.,8.7.,8.7.,8.7.,,8.7.,,
,8.8.1.,Injectable Contraceptive MPA (Intra Muscular) - First Dose ,7.5.1.,8.8.1.,8.8.1.,8.8.1.,8.8.1.,8.8.1.,8.8.1.,5.5.1.,8.8.1.,,
,8.8.2.,Injectable Contraceptive MPA (Sub Cutaneous) - First Dose ,7.5.2.,8.8.2.,8.8.2.,8.8.2.,8.8.2.,8.8.2.,8.8.2.,5.5.2.,8.8.2.,,
,8.9.1.,Injectable Contraceptive MPA (Intra Muscular) - Second Dose ,7.6.1.,8.9.1.,8.9.1.,8.9.1.,8.9.1.,8.9.1.,8.9.1.,5.6.1.,8.9.1.,,
,8.9.2.,Injectable Contraceptive MPA (Sub Cutaneous)- Second Dose ,7.6.2.,8.9.2.,8.9.2.,8.9.2.,8.9.2.,8.9.2.,8.9.2.,5.6.2.,8.9.2.,,
,8.10.1.,Injectable Contraceptive MPA (Intra Muscular) - Third Dose ,7.7.1.,8.10.1.,8.10.1.,8.10.1.,8.10.1.,8.10.1.,8.10.1.,5.7.1.,8.10.1.,,
,8.10.2.,Injectable Contraceptive MPA (Sub Cutaneous)- Third Dose ,7.7.2.,8.10.2.,8.10.2.,8.10.2.,8.10.2.,8.10.2.,8.10.2.,5.7.2.,8.10.2.,,
,8.11.1.,Injectable Contraceptive MPA (Intra Muscular) - Fourth and above Dose ,7.8.1.,8.11.1.,8.11.1.,8.11.1.,8.11.1.,8.11.1.,8.11.1.,5.8.1.,8.11.1.,,
,8.11.2.,Injectable Contraceptive MPA (Sub Cutaneous)- Fourth and above Dose ,7.8.2.,8.11.2.,8.11.2.,8.11.2.,8.11.2.,8.11.2.,8.11.2.,5.8.2.,8.11.2.,,
,8.12.,Number of Combined Oral Pill cycles distributed to the beneficiary ,7.9.,8.12.,8.12.,8.12.,8.12.,8.12.,8.12.,,8.12.,,
,8.13.,Number of Condom pieces distributed to the beneficiary ,7.10.,8.13.,8.13.,8.13.,8.13.,8.13.,8.13.,,8.13.,,
,8.14.,Number of Centchroman (weekly) pill strips distributed to the beneficiary ,7.11.,8.14.,8.14.,8.14.,8.14.,8.14.,8.14.,,8.14.,,
,8.15.,Number of Emergency Contraceptive Pills (ECP) given to the beneficiary ,7.12.,8.15.,8.15.,8.15.,8.15.,8.15.,8.15.,,8.15.,,
,8.16.,Number of Pregnancy Test Kits (PTK) utilized ,7.13.,8.16.,8.16.,8.16.,8.16.,8.16.,8.16.,,8.16.,,
,8.17.1,No. of Subdermal Contraceptive Implant inserted ,7.14.1.,8.17.1,8.17.1,8.17.1.,8.17.1,8.17.1.,8.17.1,,8.17.1.,,
,8.17.2,No. of Subdermal Contraceptive Implant removed ,7.14.2.,8.17.2,8.17.2,8.17.2.,8.17.2,8.17.2.,8.17.2,,8.17.2.,,
,8.18.1.,Complications following male sterilization ,7.15.1.,8.18.1,8.18.1.,8.18.1.,8.18.1.,8.18.1.,8.18.1,,8.18.1.,,
,8.18.2.,Complications following female sterilization ,7.15.2.,8.18.2,8.18.2.,8.18.2.,8.18.2.,8.18.2.,8.18.2,,8.18.2.,,
M8 [Family Planning],8.18.3.,Failures following male sterilization ,,8.18.3,8.18.3.,8.18.3.,8.18.3.,8.18.3.,8.18.3,,8.18.3.,,
,8.18.4.,Failures following female sterilization ,,8.18.4,8.18.4.,8.18.4.,8.18.4.,8.18.4.,8.18.4,,8.18.4.,,
,8.18.5.,Deaths following male sterilization ,,8.18.5,8.18.5.,8.18.5.,8.18.5.,8.18.5.,8.18.5,,8.18.5.,,
,8.18.6.,Deaths following female sterilization ,,8.18.6,8.18.6.,8.18.6.,8.18.6.,8.18.6.,8.18.6,,8.18.6.,,
,8.19.1.,Number of cases of Female Sterilization followed up (after 1 month or on the resumption of her menstrual cycle whichever is earlier) ,,8.19.1,8.19.1,8.19.1.,8.19.1,8.19.1.,8.19.1,,8.19.1.,,
,8.19.2.,Number of cases of Male Sterilization followed up (after 3 months) ,,8.19.2,8.19.2,8.19.2.,8.19.2,8.19.2.,8.19.2,,8.19.2.,,
M9 [CHILD IMMUNISATION],9.1.1.,Child immunisation - Vitamin K (Birth Dose) ,8.1.1.,9.1.1.,9.1.1.,9.1.1.,9.1.1.,9.1.1.,9.1.1.,6.1.1.,9.1.1.,,
,9.1.2.,Child immunisation - BCG ,8.1.2.,9.1.2.,9.1.2.,9.1.2.,9.1.2.,9.1.2.,9.1.2.,6.1.2.,9.1.2.,,
,9.1.3.,Child immunisation - Pentavalent 1 ,8.1.3.,9.1.3.,9.1.3.,9.1.3.,9.1.3.,9.1.3.,9.1.3.,6.1.3.,9.1.3.,,
,9.1.4.,Child immunisation - Pentavalent 2 ,8.1.4.,9.1.4.,9.1.4.,9.1.4.,9.1.4.,9.1.4.,9.1.4.,6.1.4.,9.1.4.,,
,9.1.5.,Child immunisation - Pentavalent 3 ,8.1.5.,9.1.5.,9.1.5.,9.1.5.,9.1.5.,9.1.5.,9.1.5.,6.1.5.,9.1.5.,,
,9.1.6.,Child immunisation - OPV 0 (Birth Dose) ,8.1.6.,9.1.6.,9.1.6.,9.1.6.,9.1.6.,9.1.6.,9.1.6.,6.1.6.,9.1.6.,,
,9.1.7.,Child immunisation - OPV1 ,8.1.7.,9.1.7.,9.1.7.,9.1.7.,9.1.7.,9.1.7.,9.1.7.,6.1.7.,9.1.7.,,
,9.1.8.,Child immunisation - OPV2 ,8.1.8.,9.1.8.,9.1.8.,9.1.8.,9.1.8.,9.1.8.,9.1.8.,6.1.8.,9.1.8.,,
,9.1.9.,Child immunisation - OPV3 ,8.1.9.,9.1.9.,9.1.9.,9.1.9.,9.1.9.,9.1.9.,9.1.9.,6.1.9.,9.1.9.,,
,9.1.10.,Child immunisation - Hepatitis-B0 (Birth Dose) ,8.1.10.,9.1.10.,9.1.10.,9.1.10.,9.1.10.,9.1.10.,9.1.10.,6.1.10.,9.1.10.,,
,9.1.11.,Child immunisation - Inactivated Injectable Polio Vaccine 1 (IPV 1) ,8.1.11.,9.1.11.,9.1.11.,9.1.11.,9.1.11.,9.1.11.,9.1.11.,6.1.11.,9.1.11.,,
,9.1.12.,Child immunisation - Inactivated Injectable Polio Vaccine 2 (IPV 2) ,8.1.12.,9.1.12.,9.1.12.,9.1.12.,9.1.12.,9.1.12.,9.1.12.,6.1.12.,9.1.12.,,
,9.1.13.,Child immunisation - Rotavirus 1 ,8.1.13.,9.1.13.,9.1.13.,9.1.13.,9.1.13.,9.1.13.,9.1.13.,6.1.13.,9.1.13.,,
,9.1.14.,Child immunisation - Rotavirus 2 ,8.1.14.,9.1.14.,9.1.14.,9.1.14.,9.1.14.,9.1.14.,9.1.14.,6.1.14.,9.1.14.,,
,9.1.15.,Child immunisation - Rotavirus 3 ,8.1.15.,9.1.15.,9.1.15.,9.1.15.,9.1.15.,9.1.15.,9.1.15.,6.1.15.,9.1.15.,,
,9.1.16.,Child immunisation - PCV1 ,8.1.16.,9.1.16.,9.1.16.,9.1.16.,9.1.16.,9.1.16.,9.1.16.,6.1.16.,9.1.16.,,
,9.1.17.,Child immunisation - PCV2 ,8.1.17.,9.1.17.,9.1.17.,9.1.17.,9.1.17.,9.1.17.,9.1.17.,6.1.17.,9.1.17.,,
,9.2.1.,Child immunisation(9 - 11 months) - Inactivated Injectable Polio Vaccine 3 (IPV 3) ,8.2.1.,9.2.1.,9.2.1.,9.2.1.,9.2.1.,9.2.1.,9.2.1.,6.2.1.,9.2.1.,,
,9.2.2.,Child immunisation (9-11months) - Measles & Rubella (MR)/Measles containing vaccine(MCV) - 1st Dose ,8.2.2.,9.2.2.,9.2.2.,9.2.2.,9.2.2.,9.2.2.,9.2.2.,6.2.2.,9.2.2.,,
,9.2.3.,Child immunisation (9-11months) - JE 1st dose ,8.2.3.,9.2.3.,9.2.3.,9.2.3.,9.2.3.,9.2.3.,9.2.3.,6.2.3.,9.2.3.,,
,9.2.4.,Child immunisation - PCV Booster ,8.2.4.,9.2.4.,9.2.4.,9.2.4.,9.2.4.,9.2.4.,9.2.4.,6.2.4.,9.2.4.,,
M9 [CHILD IMMUNISATION],9.2.5.a,FULLY IMMUNIZED children aged between 9 and <12 months- Male ,8.2.5.a,9.2.5.a,9.2.5.a,9.2.5.a,9.2.5.a,9.2.5.a,9.2.5.a,6.2.5.a,9.2.5.a,,
,9.2.5.b,FULLY IMMUNIZED children aged between 9 and <12 months- Female ,8.2.5.b,9.2.5.b,9.2.5.b,9.2.5.b,9.2.5.b,9.2.5.b,9.2.5.b,6.2.5.b,9.2.5.b,,
,9.3.1.,Child immunisation(after 12 months-delayed vaccination) - Measles & Rubella (MR)/Measles containing vaccine(MCV)- 1st Dose ,8.3.1.,9.3.1.,9.3.1.,9.3.1.,9.3.1.,9.3.1.,9.3.1.,,9.3.1.,,
,9.3.2.,Child immunisation (after 12 months-delayed vaccination) - JE 1st dose ,8.3.2.,9.3.2.,9.3.2.,9.3.2.,9.3.2.,9.3.2.,9.3.2.,,9.3.2.,,
,9.3.3.,Child immunisation - DPT 1 after 12 months of age (delayed vaccination) ,8.3.3.,9.3.3.,9.3.3.,9.3.3.,9.3.3.,9.3.3.,9.3.3.,,9.3.3.,,
,9.3.4.,Child immunisation - DPT 2 after 12 months of age (delayed vaccination) ,8.3.4.,9.3.4.,9.3.4.,9.3.4.,9.3.4.,9.3.4.,9.3.4.,,9.3.4.,,
,9.3.5.,Child immunisation - DPT 3 after 12 months of age (delayed vaccination) ,8.3.5.,9.3.5.,9.3.5.,9.3.5.,9.3.5.,9.3.5.,9.3.5.,,9.3.5.,,
,9.3.6.,Child immunisation - DPT Booster after 24 months of age (delayed vaccination) ,8.3.6.,9.3.6.,9.3.6.,9.3.6.,9.3.6.,9.3.6.,9.3.6.,,9.3.6.,,
,9.3.7.,Child immunisation - OPV Booster after 24 months of age (delayed vaccination) ,8.3.7.,9.3.7.,9.3.7.,9.3.7.,9.3.7.,9.3.7.,9.3.7.,,9.3.7.,,
,9.3.8.,Child immunisation - JE Booster after 24 months of age (delayed vaccination) ,8.3.8.,9.3.8.,9.3.8.,9.3.8.,9.3.8.,9.3.8.,9.3.8.,,9.3.8.,,
,9.4.1.,Child immunisation - Measles & Rubella (MR)/ Measles containing vaccine(MCV)- 2nd Dose (16-24 months) ,8.4.1.,9.4.1.,9.4.1.,9.4.1.,9.4.1.,9.4.1.,9.4.1.,6.3.1.,9.4.1.,,
,9.4.2.,Child immunisation - DPT 1st Booster ,8.4.2.,9.4.2.,9.4.2.,9.4.2.,9.4.2.,9.4.2.,9.4.2.,6.3.2.,9.4.2.,,
,9.4.3.,Child immunisation - OPV Booster ,8.4.3.,9.4.3.,9.4.3.,9.4.3.,9.4.3.,9.4.3.,9.4.3.,6.3.3.,9.4.3.,,
,9.4.4.,Number of children more than 16 months of age who received Japanese Encephalitis (JE) vaccine- 2nd dose (16-24 months) ,8.4.4.,9.4.4.,9.4.4.,9.4.4.,9.4.4.,9.4.4.,9.4.4.,6.3.4.,9.4.4.,,
,9.5.1.,Child Immunization- Typhoid ,8.5.1.,9.5.1.,9.5.1.,9.5.1.,9.5.1.,9.5.1.,9.5.1.,,9.5.1.,,
,9.5.2.,Children more than 5 years received DPT5 (2nd Booster) ,8.5.2.,9.5.2.,9.5.2.,9.5.2.,9.5.2.,9.5.2.,9.5.2.,6.4.1.,9.5.2.,,
,9.5.3.,Children more than 10 years received Td10 (Tetanus Diptheria10) ,8.5.3.,9.5.3.,9.5.3.,9.5.3.,9.5.3.,9.5.3.,9.5.3.,6.4.2.,9.5.3.,,
,9.5.4.,Children more than 16 years received Td16 (Tetanus Diptheria16) ,8.5.4.,9.5.4.,9.5.4.,9.5.4.,9.5.4.,9.5.4.,9.5.4.,6.4.3.,9.5.4.,,
,9.6.1.,"Number of cases of AEFI -Minor (eg.- fever, rash, pain etc) ",8.6.1.,9.6.1.,9.6.1.,9.6.1.,9.6.1.,9.6.1.,9.6.1.,,9.6.1.,,
,9.6.2.,"Number of cases of AEFI - Severe (eg.- anaphylaxis, fever>102 degrees, not requiring hospitalization etc.) ",8.6.2.,9.6.2.,9.6.2.,9.6.2.,9.6.2.,9.6.2.,9.6.2.,,9.6.2.,,
M9 [CHILD IMMUNISATION],9.6.3.,"Number of cases of AEFI - Serious (eg.- hospitalization, death, disability , cluster etc.) ",8.6.3.,9.6.3.,9.6.3.,9.6.3.,9.6.3.,9.6.3.,9.6.3.,6.5.1.,9.6.3.,,
,9.6.3.a,"Out of Number of cases of AEFI - Serious , total number of AEFI deaths ",8.6.3.a,9.6.3.a,9.6.3.a,9.6.3.a,9.6.3.a,9.6.3.a,9.6.3.a,6.5.1.a,9.6.3.a,,
,9.7.1.,Immunisation sessions planned ,8.7.1.,9.7.1.,9.7.1.,9.7.1.,9.7.1.,,9.7.1.,,9.7.1.,,
,9.7.2.,Immunisation sessions held ,8.7.2.,9.7.2.,9.7.2.,9.7.2.,9.7.2.,,9.7.2.,,9.7.2.,,
,9.8.1.,Child immunisation - Vitamin A Dose - 1 ,8.8.1.,9.8.1.,9.8.1.,9.8.1.,9.8.1.,9.7.1.,9.8.1.,6.6.1.,9.8.1.,,
,9.8.2.,Child immunisation - Vitamin A Dose - 5 ,8.8.2.,9.8.2.,9.8.2.,9.8.2.,9.8.2.,9.7.2.,9.8.2.,6.6.2.,9.8.2.,,
,9.8.3.,Child immunisation - Vitamin A Dose - 9 ,8.8.3.,9.8.3.,9.8.3.,9.8.3.,9.8.3.,9.7.3.,9.8.3.,6.6.3.,9.8.3.,,
M10 [Number of cases of Childhood Diseases],10.1.1.,Childhood Diseases - Pneumonia ,,10.1.1.,10.1.1.,10.1.1.,10.1.1.,10.1.1.,10.1.1.,,10.1.1.,,
,10.1.2.,Childhood Diseases - Asthma ,,10.1.2.,10.1.2.,10.1.2.,10.1.2.,10.1.2.,10.1.2.,,10.1.2.,,
,10.1.3.,Childhood Diseases - Sepsis ,,10.1.3.,10.1.3.,10.1.3.,10.1.3.,10.1.3.,10.1.3.,,10.1.3.,,
,10.1.4.,Childhood Diseases - Diphtheria ,,10.1.4.,10.1.4.,10.1.4.,10.1.4.,10.1.4.,10.1.4.,,10.1.4.,,
,10.1.5.,Childhood Diseases - Pertussis ,,10.1.5.,10.1.5.,10.1.5.,10.1.5.,10.1.5.,10.1.5.,,10.1.5.,,
,10.1.6.,Childhood Diseases - Tetanus Neonatorum ,,10.1.6.,10.1.6.,10.1.6.,10.1.6.,10.1.6.,10.1.6.,,10.1.6.,,
,10.1.7.,Childhood Diseases - Tuberculosis (TB) ,,10.1.7.,10.1.7.,10.1.7.,10.1.7.,10.1.7.,10.1.7.,,10.1.7.,,
,10.1.8.,Childhood Diseases - Acute Flaccid Paralysis(AFP) ,,10.1.8.,10.1.8.,10.1.8.,10.1.8.,10.1.8.,10.1.8.,,10.1.8.,,
,10.1.9.,Childhood Diseases - Measles ,,10.1.9.,10.1.9.,10.1.9.,10.1.9.,10.1.9.,10.1.9.,,10.1.9.,,
,10.1.10.,Childhood Diseases - Malaria ,9.1.1.,10.1.10.,10.1.10.,10.1.10.,10.1.10.,10.1.10.,10.1.10.,,10.1.10.,,
,10.1.11.,Childhood Diseases - Diarrhoea ,9.1.2.,10.1.11.,10.1.11.,10.1.11.,10.1.11.,10.1.11.,10.1.11.,,10.1.11.,,
,10.1.12.,Childhood Diseases - Diarrhoea treated with ORS ,9.1.3.,10.1.12.,10.1.12.,10.1.12.,10.1.12.,10.1.12.,10.1.12.,,10.1.12.,,
,10.1.13.,Childhood Diseases - Diarrhoea treated with Zinc for 14 days ,9.1.4.,10.1.13.,10.1.13.,10.1.13.,10.1.13.,10.1.13.,10.1.13.,,10.1.13.,,
,10.1.14.,Childhood Diseases -Leprosy Cases ,,10.1.14.,10.1.14.,10.1.14.,10.1.14.,10.1.14.,10.1.14.,,10.1.14.,,
M10 [Number of cases of Childhood Diseases],10.1.15.,Childhood Diseases- Leprosy with Grade II disability ,,10.1.15.,10.1.15.,10.1.15.,10.1.15.,10.1.15.,10.1.15.,,10.1.15.,,
,10.2.1.,Children admitted with Respiratory Infections ,,10.2.1.,10.2.1.,10.2.1.,10.2.1.,10.2.1.,10.2.1.,,10.2.1.,,
,10.2.2.,Children admitted with Pneumonia ,,10.2.2.,10.2.2.,10.2.2.,10.2.2.,10.2.2.,10.2.2.,,10.2.2.,,
,10.2.3.,Children admitted with Diarrhoea ,,10.2.3.,10.2.3.,10.2.3.,10.2.3.,10.2.3.,10.2.3.,,10.2.3.,,
M11 [NVBDCP],11.1.1.a,Total Blood Smears Examined for Malaria ,,11.1.1.a,11.1.1.a,11.1.1.a,11.1.1.a,11.1.1.a,11.1.1.a,,11.1.1.a,,
,11.1.1.b,Malaria (Microscopy Tests ) - Plasmodium Vivax test positive ,,11.1.1.b,11.1.1.b,11.1.1.b,11.1.1.b,11.1.1.b,11.1.1.b,,11.1.1.b,,
M11 [NVBDCP],11.1.1.c,Malaria (Microscopy Tests ) - Plasmodium Falciparum test positive ,,11.1.1.c,11.1.1.c,11.1.1.c,11.1.1.c,11.1.1.c,11.1.1.c,,11.1.1.c,,
,11.1.1.d,Malaria (Microscopy Tests ) - Mixed test positive ,,11.1.1.d,11.1.1.d,11.1.1.d,11.1.1.d,11.1.1.d,11.1.1.d,,11.1.1.d,,
,11.1.2.a,RDT conducted for Malaria ,10.1.1.a,11.1.2.a,11.1.2.a,11.1.2.a,11.1.2.a,11.1.2.a,11.1.2.a,,11.1.2.a,,
,11.1.2.b,Malaria (RDT) - Plasmodium Vivax test positive ,10.1.1.b,11.1.2.b,11.1.2.b,11.1.2.b,11.1.2.b,11.1.2.b,11.1.2.b,,11.1.2.b,,
,11.1.2.c,Malaria (RDT) - Plasmodium Falciparum test positive ,10.1.1.c,11.1.2.c,11.1.2.c,11.1.2.c,11.1.2.c,11.1.2.c,11.1.2.c,,11.1.2.c,,
,11.1.2.d,Malaria (RDT) - Mixed test positive ,10.1.1.d,11.1.2.d,11.1.2.d,11.1.2.d,11.1.2.d,11.1.2.d,11.1.2.d,,11.1.2.d,,
,11.2.1.,Kala Azar (RDT) - Tests Conducted ,,11.2.1.,11.2.1.,11.2.1.,11.2.1.,11.2.1.,11.2.1.,,11.2.1.,,
,11.2.2.,Kala Azar Positive Cases ,,11.2.2.,11.2.2.,11.2.2.,11.2.2.,11.2.2.,11.2.2.,,11.2.2.,,
,11.3.1.,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted ,,,,11.3.1.,11.3.1.,11.3.1.,,,11.3.1.,,
,11.3.2.,Dengue - Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive ,,,,11.3.2.,11.3.2.,11.3.2.,,,11.3.2.,,
,11.3.3.,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test conducted ,,,,11.3.3.,11.3.3.,11.3.3.,,,11.3.3.,,
,11.3.4.,Chikungunya Enzyme- Linked Immuno Sorbent Assay (ELISA) test found positive ,,,,11.3.4.,11.3.4.,11.3.4.,,,11.3.4.,,
,11.4.1.,No. of AES cases tested for JE(IgM ELISA) ,,,,11.4.1.,11.4.1.,11.4.1.,,,11.4.1.,,
,11.4.2.,No. of JE positive cases ,,,,11.4.2.,11.4.2.,11.4.2.,,,11.4.2.,,
,11.5.1.,Number of persons that consumed MDA(Mass Drug Administration) drugs during the MDA round ,10.2.1.,11.3.1.,11.3.1.,11.5.1.,11.5.1.,11.5.1.,11.3.1.,,11.5.1.,,
,11.5.2.,Number of Lymphatic Filarisis lymphoedema patients received MMDP (Morbidity Management And Disability Prevention) kits ,10.2.2.,11.3.2.,11.3.2.,11.5.2.,11.5.2.,11.5.2.,11.3.2.,,11.5.2.,,
,11.5.3.,Number of Hydrocele surgeries conducted in Lymphatic Filariasis (MMDP) ,,,11.3.3.,11.5.3.,11.5.3.,11.5.3.,,,11.5.3.,,
M12 [Adolescent Health],12.1.1.a,Girls registered in AFHC ,,12.1.1.a,12.1.1.a,12.1.1.a,12.1.1.a,12.1.1.a,12.1.1.a,,12.1.1.a,,
,12.1.1.b,Boys registered in AFHC ,,12.1.1.b,12.1.1.b,12.1.1.b,12.1.1.b,12.1.1.b,12.1.1.b,,12.1.1.b,,
,12.1.2.a,"Out of Girls registered, Girls received clinical services ",,12.1.2.a,12.1.2.a,12.1.2.a,12.1.2.a,12.1.2.a,12.1.2.a,,12.1.2.a,,
,12.1.2.b,"Out of Boys registered, Boys received clinical services ",,12.1.2.b,12.1.2.b,12.1.2.b,12.1.2.b,12.1.2.b,12.1.2.b,,12.1.2.b,,
,12.1.3.a,"Out of Girls registered, Girls received counselling ",,12.1.3.a,12.1.3.a,12.1.3.a,12.1.3.a,12.1.3.a,12.1.3.a,,12.1.3.a,,
,12.1.3.b,"Out of Boys registered, Boys received counselling ",,12.1.3.b,12.1.3.b,12.1.3.b,12.1.3.b,12.1.3.b,12.1.3.b,,12.1.3.b,,
,12.2.1.a,Number of Girls (6th -12th class) provided 4/5 IFA tablets in schools,,,,,,,,,,2.3.1.a,
M12 [Adolescent Health],12.2.1.b,Number of Boys (6th -12th class) provided 4/5 IFA tablets in schools,,,,,,,,,,2.3.1.b,
,12.2.2.a,Number of Girls (6th -12th class) provided albendazole in schools,,,,,,,,,,2.3.2.a,
,12.2.2.b,Number of Boys (6th -12th class) provided albendazole in schools,,,,,,,,,,2.3.2.b,
,12.2.3.,Number of out of school adolescent girls (10-19 years) provided 4/5 IFA tablets at Anganwadi Centres,,,,,,,,,,2.3.3.,
,12.2.4.,Number of out of school adolescent girls (10-19 years) provided albendazole tablet at Anganwadi Centres,,,,,,,,,,2.3.4.,
,12.3.1.,Number of adolescent girls provided sanitary napkin packs by ASHA,11.1.1.,12.2.1.,12.2.1.,12.2.1,12.2.1,,12.2.1.,,12.2.1,,
,12.3.2.,Number of sanitary napkin packs distributed free to ASHA (for her personal use) ,11.1.2.,12.2.2.,12.2.2.,12.2.2,12.2.2,,12.2.2.,,12.2.2,,
,12.3.3.,Number of adolescent girls attended monthly meeting ,11.1.3.,12.2.3.,12.2.3.,12.2.3,12.2.3,,12.2.3.,,12.2.3,,
,12.3.4.,Number of adolescent girls provided sanitary napkin packs by State/UT supported Menstrual Hygiene Scheme (MHS) ,11.1.4.,12.2.4.,12.2.4.,12.2.4,12.2.4,,12.2.4.,,12.2.4,,
,12.4.1.,Number of Peer Educators selected ,11.2.1.,12.3.1.,,,,,12.3.1.,,,,
,12.4.2.,"Out of the selected Peer Educators, numbers trained ",11.2.2.,12.3.2.,,,,,12.3.2.,,,,
,12.4.3.,Number of Adolescent Health & Wellness Days organized ,11.2.3.,12.3.3.,12.3.1.,12.3.1.,12.3.1.,,12.3.3.,,12.3.1.,,
,12.4.4.,Number of Adolescent Friendly Club Meetings organized ,11.2.4.,12.3.4.,,,,,12.3.4.,,,,
M13 [National TB Elimination Programme (NTEP)],13.1.,Number of beneficiaries who are registered at the ICTC centre. ,,,13.1.,13.1.,13.1.,13.1.,,,13.1.,,
,13.2.,"Of the number registered at ICTC centre, the number of presumptive TB cases identified and referred for TB testing and diagnosis ",,,13.2.,13.2.,13.2.,13.2.,,,13.2.,,
,13.3.,Number of beneficiaries who are registered at the NCD clinic. ,,,13.3.,13.3.,13.3.,13.3.,,,13.3.,,
,13.4.,The number registered at the NCD clinic includes the number of presumptive TB cases identified and referred for TB testing and diagnosis ,,,13.4.,13.4.,13.4.,13.4.,,,13.4.,,
M14 [Patient Services],14.1.1.a,Total number of geriatric/elderly patients (age>=60 yrs) Registered ,12.1.1.a,13.1.1.a,14.1.1.a,14.1.1.a,14.1.1.a,14.1.1.a,13.1.1.a,,14.1.1.a,,
,14.1.1.b,Geriatric (age>=60 yrs) patients footfall ,12.1.1.b,13.1.1.b,14.1.1.b,14.1.1.b,14.1.1.b,14.1.1.b,13.1.1.b,,14.1.1.b,,
,14.1.1.c,Number of geriatric/elderly persons who underwent Comprehensive Geriatric Assessment by CHO ,12.1.1.c,13.1.1.c,,,,,13.1.1.c,,,,
,14.1.1.d,Number of geriatric/elderly persons managed for any elderly conditions ,12.1.1.d,13.1.1.d,14.1.1.c,14.1.1.c,14.1.1.c,14.1.1.c,13.1.1.d,,14.1.1.c,,
,14.1.1.e,Number of geriatric/elderly persons followed-up for any elderly conditions ,12.1.1.e,13.1.1.e,14.1.1.d,14.1.1.d,14.1.1.d,14.1.1.d,13.1.1.e,,14.1.1.d,,
,14.1.1.f,Number of geriatric/elderly patients (age>=60 yrs) provided physiotherapy services ,12.1.1.f,13.1.1.f,14.1.1.e,14.1.1.e,14.1.1.e,14.1.1.e,13.1.1.f,,14.1.1.e,,
,14.1.1.g,Number of home bound (bed bound & restricted mobility) elderly and single elderly visited by ASHA & ANM/MPW-M during the month ,12.1.1.g,13.1.1.g,14.1.1.f,14.1.1.f,14.1.1.f,,13.1.1.g,,14.1.1.f,,
M14 [Patient Services],14.1.1.h,Number of elderly support groups-‘Sanjeevini’ created during the month ,12.1.1.h,13.1.1.h,,,,,13.1.1.h,,,,
,14.1.1.i,Number of weekly geriatric clinics organized during the month ,12.1.1.i,13.1.1.i,,,,,13.1.1.i,,,,
,14.1.1.j,Number of fixed day rehabilitation services provided during the month ,12.1.1.j,13.1.1.j,,,,,13.1.1.j,,,,
,14.1.2.a.,Number of patients provided physiotherapy services ,,13.1.2.a,14.1.2.a,14.1.2.a,14.1.2.a,14.1.2.a,13.1.2.a,,14.1.2.a,,
,14.1.2.b.,Number of Palliative Patients visited at home ,12.1.2.a,13.1.2.b,14.1.2.b,14.1.2.b,14.1.2.b,,13.1.2.b,,14.1.2.b,,
,14.1.2.c.,Number of visits for home care/ end of life care provided by AAM-PHC team ,,13.1.2.c,,,,,13.1.2.c,,,,
,14.1.2.d.,Number of weekly palliative care OPD conducted at AAM-PHC ,12.1.2.b,13.1.2.d,,,,,13.1.2.d,,,,
,14.1.2.e.,Number of cases reported for Self Harm ,12.1.2.c,13.1.2.e,14.1.2.c,14.1.2.c,14.1.2.c,14.1.2.b,13.1.2.e,,14.1.2.c,,
,14.1.3.a,Total number of footfall in outreach camps/sessions ,12.1.3.a.,13.1.3.a,14.1.3.a,14.1.3.a,14.1.3.a,,13.1.3.a,,14.1.3.a,,
,14.1.3.b,Total number cases examined in outreach camps for Mental illness ,12.1.3.b.,13.1.3.b,14.1.3.b,14.1.3.b,14.1.3.b,,13.1.3.b,,14.1.3.b,,
,14.1.4.,Number of psychoeducation sessions conducted at the Ayushman Arogya Mandir during the month ,12.1.4.,13.1.3.c,,,,,13.1.3.c,,,,
,14.2.1.,Allopathic- Outpatient attendance ,12.2.1.,13.2.1.,14.2.1.,14.2.1.,14.2.1.,14.2.1.,13.2.1.,7.1.1.,14.2.1.,,
,14.2.1.a,"Out of above, number of specialist Allopathic OPD services provided ",12.2.1.a,13.2.1.a,14.2.1.a,14.2.1.a,14.2.1.a,14.2.1.a,13.2.1.a,,14.2.1.a,,
,14.2.2.,Ayush - Outpatient attendance ,12.2.2.,13.2.2.,14.2.2.,14.2.2.,14.2.2.,14.2.2.,13.2.2.,7.1.2.,14.2.2.,,
,14.2.2.b,"Out of above, number of specialist AYUSH OPD services provided ",12.2.2.a,13.2.2.a,14.2.2.a,14.2.2.a,14.2.2.a,14.2.2.a,13.2.2.a,,14.2.2.a,,
,14.3.1.a,IPD Admission Male- Children<18yrs ,,13.3.1.a,14.3.1.a,14.3.1.a,14.3.1.a,14.3.1.a,13.3.1.a,7.2.1.a,14.3.1.a,,
,14.3.1.b,IPD Admission Male- Adults <60yrs ,,13.3.1.b,14.3.1.b,14.3.1.b,14.3.1.b,14.3.1.b,13.3.1.b,7.2.1.b,14.3.1.b,,
,14.3.1.c,IPD Admission Female- Children<18yrs ,,13.3.1.c,14.3.1.c,14.3.1.c,14.3.1.c,14.3.1.c,13.3.1.c,7.2.1.c,14.3.1.c,,
,14.3.1.d,IPD Admission Female- Adults<60yrs ,,13.3.1.d,14.3.1.d,14.3.1.d,14.3.1.d,14.3.1.d,13.3.1.d,7.2.1.d,14.3.1.d,,
,14.3.1.e,IPD Admission Geriatric->=60yrs ,,13.3.1.e,14.3.1.e,14.3.1.e,14.3.1.e,14.3.1.e,13.3.1.e,7.2.1.e,14.3.1.e,,
,14.3.2.a,IPD Discharge Male- Children<18yrs ,,13.3.2.a,14.3.2.a,14.3.2.a,14.3.2.a,14.3.2.a,13.3.2.a,7.2.2.a,14.3.2.a,,
,14.3.2.b,IPD Discharge Male- Adults<60yrs ,,13.3.2.b,14.3.2.b,14.3.2.b,14.3.2.b,14.3.2.b,13.3.2.b,7.2.2.b,14.3.2.b,,
,14.3.2.c,IPD Discharge Female- Children<18yrs ,,13.3.2.c,14.3.2.c,14.3.2.c,14.3.2.c,14.3.2.c,13.3.2.c,7.2.2.c,14.3.2.c,,
,14.3.2.d,IPD Discharge Female- Adults<60yrs ,,13.3.2.d,14.3.2.d,14.3.2.d,14.3.2.d,14.3.2.d,13.3.2.d,7.2.2.d,14.3.2.d,,
,14.3.2.e,IPD Discharge Geriatric->=60yrs ,,13.3.2.e,14.3.2.e,14.3.2.e,14.3.2.e,14.3.2.e,13.3.2.e,7.2.2.e,14.3.2.e,,
,14.3.3.a,IPD Referred Male- Children<18yrs ,,13.3.3.a,14.3.3.a,14.3.3.a,14.3.3.a,14.3.3.a,13.3.3.a,,14.3.3.a,,
,14.3.3.b,IPD Referred Male- Adults<60yrs ,,13.3.3.b,14.3.3.b,14.3.3.b,14.3.3.b,14.3.3.b,13.3.3.b,,14.3.3.b,,
,14.3.3.c,IPD Referred Female- Children<18yrs ,,13.3.3.c,14.3.3.c,14.3.3.c,14.3.3.c,14.3.3.c,13.3.3.c,,14.3.3.c,,
,14.3.3.d,IPD Referred Female- Adults<60yrs ,,13.3.3.d,14.3.3.d,14.3.3.d,14.3.3.d,14.3.3.d,13.3.3.d,,14.3.3.d,,
,14.3.3.e,IPD Referred Geriatric->=60yrs ,,13.3.3.e,14.3.3.e,14.3.3.e,14.3.3.e,14.3.3.e,13.3.3.e,,14.3.3.e,,
,14.3.4.a,IPD Deaths Male- Children<18yrs ,,13.3.4.a,14.3.4.a,14.3.4.a,14.3.4.a,14.3.4.a,13.3.4.a,7.2.3.a,14.3.4.a,,
,14.3.4.b,IPD Deaths Male- Adults<60yrs ,,13.3.4.b,14.3.4.b,14.3.4.b,14.3.4.b,14.3.4.b,13.3.4.b,7.2.3.b,14.3.4.b,,
M14 [Patient Services],14.3.4.c,IPD Deaths Female- Children<18yrs ,,13.3.4.c,14.3.4.c,14.3.4.c,14.3.4.c,14.3.4.c,13.3.4.c,7.2.3.c,14.3.4.c,,
,14.3.4.d,IPD Deaths Female- Adults<60yrs ,,13.3.4.d,14.3.4.d,14.3.4.d,14.3.4.d,14.3.4.d,13.3.4.d,7.2.3.d,14.3.4.d,,
,14.3.4.e,IPD Deaths Geriatric->=60yrs ,,13.3.4.e,14.3.4.e,14.3.4.e,14.3.4.e,14.3.4.e,13.3.4.e,7.2.3.e,14.3.4.e,,
,14.3.5.a,Total cases Referred out (OPD+IPD+Emergency)-During Day ,12.3.1.,13.3.5.a,14.3.5.a,14.3.5.a,14.3.5.a,14.3.5.a,13.3.5.a,7.2.4.a,14.3.5.a,,
,14.3.5.b,Total cases Referred out (OPD+IPD+Emergency)-At Night (8 PM- 8 AM) ,,13.3.5.b,14.3.5.b,14.3.5.b,14.3.5.b,14.3.5.b,13.3.5.b,7.2.4.b,14.3.5.b,,
,14.3.6.,Day Care Admissions ,12.4.,13.3.6.,14.3.6.,14.3.6.,14.3.6.,14.3.6.,13.3.6.,7.2.5.,14.3.6.,,
,14.3.7.a,Number of Total Left Against Medical Advice (LAMA) cases reported at the facility ,,13.3.7.a,14.3.7.a,14.3.7.a,14.3.7.a,14.3.7.a,13.3.7.a,,14.3.7.a,,
,14.3.7.b,Number of delivery LAMA cases reported at the facility ,,13.3.7.b,14.3.7.b,14.3.7.b,14.3.7.b,14.3.7.b,13.3.7.b,,14.3.7.b,,
,14.3.8,Total number of Medico Legal Cases reported at the facility ,,13.3.8.,14.3.8.,14.3.8.,14.3.8.,14.3.8.,13.3.8.,,14.3.8.,,
,14.3.9,Total number of postmortem conducted at the facility ,,,14.3.9.,14.3.9.,14.3.9.,14.3.9.,,,14.3.9.,,
,14.3.10.,Total number of telemedicine consultation provided ,12.5.,13.3.9.,14.3.10.,14.3.10.,14.3.10.,14.3.10.,13.3.9.,,14.3.10.,,
,14.4.1.,Inpatient - Malaria ,,13.4.1.,14.4.1.,14.4.1.,14.4.1.,14.4.1.,13.4.1.,,14.4.1.,,
,14.4.2.,Inpatient - Dengue ,,13.4.2.,14.4.2.,14.4.2.,14.4.2.,14.4.2.,13.4.2.,,14.4.2.,,
,14.4.3.,Inpatient - Typhoid ,,13.4.3.,14.4.3.,14.4.3.,14.4.3.,14.4.3.,13.4.3.,,14.4.3.,,
,14.4.4.,"Inpatient - Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory infections ",,13.4.4.,14.4.4.,14.4.4.,14.4.4.,14.4.4.,13.4.4.,,14.4.4.,,
,14.4.5.,Inpatient - Tuberculosis ,,13.4.5.,14.4.5.,14.4.5.,14.4.5.,14.4.5.,13.4.5.,,14.4.5.,,
,14.4.6.,Inpatient - Pyrexia of unknown origin (PUO) ,,13.4.6.,14.4.6.,14.4.6.,14.4.6.,14.4.6.,13.4.6.,,14.4.6.,,
,14.4.7.,Inpatient - Diarrhoea with dehydration ,,13.4.7.,14.4.7.,14.4.7.,14.4.7.,14.4.7.,13.4.7.,,14.4.7.,,
,14.4.8.,Inpatient – Leprosy (Reconstructive Surgery) ,,,,14.4.8.,14.4.8.,14.4.8.,,,14.4.8.,,
,14.4.9.,Inpatient – Operated for Cataract ,,,14.4.8.,14.4.9.,14.4.9.,14.4.9.,,,14.4.9.,,
,14.4.10.,Inpatient – Palliative Care ,,13.4.8.,14.4.9.,14.4.10.,14.4.10.,14.4.10.,13.4.8.,,14.4.10.,,
,14.4.11.,Inpatient – Mental illness ,,,,,14.4.11.,14.4.11.,,,,,
,14.5.1.,Patients registered at Emergency Department ,,13.5.1.,14.5.1.,14.5.1.,14.5.1.,14.5.1.,13.5.1.,,14.5.1.,,
,14.5.2.,No. of Emergencies managed at night (8 PM- 8 AM) ,,13.5.2.,14.5.2.,14.5.2.,14.5.2.,14.5.2.,13.5.2.,,14.5.2.,,
,14.5.3.,Total Number of Emergency cases managed ,12.6.1.,13.5.3.,14.5.3.,14.5.3.,14.5.3.,14.5.3.,13.5.3.,,14.5.3.,,
,14.5.4.,Total Number of Emergency cases referred out ,,13.5.4.,14.5.4.,14.5.4.,14.5.4.,14.5.4.,13.5.4.,,14.5.4.,,
,14.5.5.,Total Number of CPR performed in the emergency ,12.6.2.,13.5.5.,14.5.5.,14.5.5.,14.5.5.,14.5.5.,13.5.5.,,14.5.5.,,
,14.6.1.a,"Emergency - Trauma ( accident, injury, poisoning etc) -Admission ",,13.6.1.a,14.6.1.a,14.6.1.a,14.6.1.a,14.6.1.a,13.6.1.a,,14.6.1.a,,
,14.6.1.b,"Emergency - Trauma ( accident, injury, poisoning etc) -Deaths ",,13.6.1.b,14.6.1.b,14.6.1.b,14.6.1.b,14.6.1.b,13.6.1.b,,14.6.1.b,,
,14.6.2.a,Emergency - Burn -Admission ,,13.6.2.a,14.6.2.a,14.6.2.a,14.6.2.a,14.6.2.a,13.6.2.a,,14.6.2.a,,
,14.6.2.b,Emergency - Burn -Deaths ,,13.6.2.b,14.6.2.b,14.6.2.b,14.6.2.b,14.6.2.b,13.6.2.b,,14.6.2.b,,
,14.6.3.a,Emergency - Obstetrics complications -Admission ,,13.6.3.a,14.6.3.a,14.6.3.a,14.6.3.a,14.6.3.a,13.6.3.a,,14.6.3.a,,
,14.6.3.b,Emergency - Obstetrics complications -Deaths ,,13.6.3.b,14.6.3.b,14.6.3.b,14.6.3.b,14.6.3.b,13.6.3.b,,14.6.3.b,,
,14.6.4.a,Emergency - Snake Bite -Admission ,,13.6.4.a,14.6.4.a,14.6.4.a,14.6.4.a,14.6.4.a,13.6.4.a,,14.6.4.a,,
M14 [Patient Services],14.6.4.b,Emergency - Snake Bite -Deaths ,,13.6.4.b,14.6.4.b,14.6.4.b,14.6.4.b,14.6.4.b,13.6.4.b,,14.6.4.b,,
,14.6.5.a,Emergency - Acute Cardiac Emergencies -Admission ,,13.6.5.a,14.6.5.a,14.6.5.a,14.6.5.a,14.6.5.a,13.6.5.a,,14.6.5.a,,
,14.6.5.b,Emergency - Acute Cardiac Emergencies -Deaths ,,13.6.5.b,14.6.5.b,14.6.5.b,14.6.5.b,14.6.5.b,13.6.5.b,,14.6.5.b,,
,14.6.6.a,Emergency - CVA (Cerebrovascular Disease)/Stroke -Admission ,,13.6.6.a,14.6.6.a,14.6.6.a,14.6.6.a,14.6.6.a,13.6.6.a,,14.6.6.a,,
,14.6.6.b,Emergency - CVA (Cerebrovascular Disease)/Stroke -Deaths ,,13.6.6.b,14.6.6.b,14.6.6.b,14.6.6.b,14.6.6.b,13.6.6.b,,14.6.6.b,,
,14.6.7.a,Emergency - Dog Bite -Admission ,,13.6.7.a,14.6.7.a,14.6.7.a,14.6.7.a,14.6.7.a,13.6.7.a,,14.6.7.a,,
,14.6.7.b,Emergency - Dog Bite -Deaths ,,13.6.7.b,14.6.7.b,14.6.7.b,14.6.7.b,14.6.7.b,13.6.7.b,,14.6.7.b,,
,14.7.,Total number of deaths occurring at Emergency Department ,,13.7.,14.7.,14.7.,14.7.,14.7.,13.7.,,14.7.,,
,14.8.1.a,Total number of Major Operations conducted excluding C-Section (General and spinal anaesthesia) ,,,14.8.1.a,14.8.1.a,14.8.1.a,14.8.1.a,,7.3.1.,14.8.1.a,,
,14.8.1.b,"Out of Major Operation, Gynecology- Hysterectomy surgeries ",,,14.8.1.b,14.8.1.b,14.8.1.b,14.8.1.b,,,14.8.1.b,,
,14.8.1.c,"Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology. ",,,,14.8.1.c,14.8.1.c,14.8.1.c,,,14.8.1.c,,
,14.8.1.d,No. of Major Surgeries done at night (8PM to 8 AM) (Excluding C section) ,,,14.8.1.c,14.8.1.d,14.8.1.d,14.8.1.d,,,14.8.1.d,,
,14.8.2.,Minor Operations (No or local anaesthesia) ,,13.8.,14.8.2.,14.8.2.,14.8.2.,14.8.2.,13.8.,7.3.2.,14.8.2.,,
,14.9.,Number of post operative Surgical Site infection ,,,14.8.3.,14.8.3.,14.8.3.,14.8.3.,,,14.8.3.,,
,14.10.,In-Patient Head Count at midnight ,,13.9.,14.9.,14.9.,14.9.,14.9.,13.9.,7.4.,14.9.,,
,14.11.1,Number of Admission in NBSU ( New Born Stabilisation Unit) ,,13.10.1.,14.10.1.,14.10.1.,14.10.1,,13.10.1.,,14.10.1.,,
,14.11.2.,Number of total admissions in Special Newborn Care Unit (SNCU Admissions) ,,,14.10.2.,14.10.2.,14.10.2.,14.10.1.,,,14.10.2.,,
,14.12.1,Number of deaths occurred at SNCU ,,,14.11.1.,14.11.1.,14.11.1,14.11.1,,,14.11.1.,,
,14.12.2,Number of Newborns successfully discharged from SNCU ,,,14.11.2.,14.11.2.,14.11.2,14.11.2,,,14.11.2.,,
,14.13.1.a.i,Number of pregnant women provided free medicines during ANC period under JSSK ,12.7.1.a.i,13.11.1.a.i,14.12.1.a.i,14.12.1.a.i,14.12.1.a.i,14.12.1.a.i,13.11.1.a.i,,14.12.1.a.i,,
,14.13.1.a.ii,Number of Pregnant women provided free medicines during delivery under JSSK ,12.7.1.a.ii,13.11.1.a.ii,14.12.1.a.ii,14.12.1.a.ii,14.12.1.a.ii,14.12.1.a.ii,13.11.1.a.ii,,14.12.1.a.ii,,
,14.13.1.a.iii,Number of PNC mothers provided free medicines under JSSK ,12.7.1.a.iii,13.11.1.a.iii,14.12.1.a.iii,14.12.1.a.iii,14.12.1.a.iii,14.12.1.a.iii,13.11.1.a.iii,,14.12.1.a.iii,,
,14.13.1.b,Number of women provided - Free Diet under JSSK ,12.7.1.b.,13.11.1.b,14.12.1.b,14.12.1.b,14.12.1.b,14.12.1.b,13.11.1.b,,14.12.1.b,,
,14.13.1.c.i,Number of pregnant women provided free diagnostics during ANC period under JSSK ,12.7.1.c.i,13.11.1.c.i,14.12.1.c.i,14.12.1.c.i,14.12.1.c.i,14.12.1.c.i,13.11.1.c.i,,14.12.1.c.i,,
,14.13.1.c.ii,Number of Pregnant women provided free diagnostics during delivery under JSSK ,12.7.1.c.ii,13.11.1.c.ii,14.12.1.c.ii,14.12.1.c.ii,14.12.1.c.ii,14.12.1.c.ii,13.11.1.c.ii,,14.12.1.c.ii,,
,14.13.1.c.iii,Number of PNC mothers provided free diagnostics under JSSK ,12.7.1.c.iii,13.11.1.c.iii,14.12.1.c.iii,14.12.1.c.iii,14.12.1.c.iii,14.12.1.c.iii,13.11.1.c.iii,,14.12.1.c.iii,,
,14.13.1.d,Number ofpregnant women provided - Free Home to facility transport for conducting delivery under JSSK ,12.7.1.d,13.11.1.d,14.12.1.d,14.12.1.d,14.12.1.d,14.12.1.d,13.11.1.d,,14.12.1.d,,
,14.13.1.e,Number of pregnant women provided - Interfacility transfers when needed during delivery under JSSK(in case of referral) ,12.7.1.e,13.11.1.e,14.12.1.e,14.12.1.e,14.12.1.e,14.12.1.e,13.11.1.e,,14.12.1.e,,
M14 [Patient Services],14.13.1.f,Number of PNC mothers provided - Free Drop Back home after delivery under JSSK ,12.7.1.f,13.11.1.f,14.12.1.f,14.12.1.f,14.12.1.f,14.12.1.f,13.11.1.f,,14.12.1.f,,
,14.13.2.a,Number of infants admitted at facility due to any sickness- JSSK Beneficiaries ,12.7.2.a,13.11.2.a,14.12.2.a,14.12.2.a,14.12.2.a,14.12.2.a,13.11.2.a,,14.12.2.a,,
,14.13.2.b,Number of sick infants provided - Free Medicines under JSSK ,12.7.2.b,13.11.2.b,14.12.2.b,14.12.2.b,14.12.2.b,14.12.2.b,13.11.2.b,,14.12.2.b,,
,14.13.2.c,Number of sick infants provided - Free Diagnostics under JSSK ,,13.11.2.c,14.12.2.c,14.12.2.c,14.12.2.c,14.12.2.c,13.11.2.c,,14.12.2.c,,
,14.13.2.d,Number of sick infants provided - Free Home to facility transport under JSSK ,12.7.2.c,13.11.2.d,14.12.2.d,14.12.2.d,14.12.2.d,14.12.2.d,13.11.2.d,,14.12.2.d,,
,14.13.2.e,Number of infants received free referral transport under JSSK ,12.7.2.d,13.11.2.e,14.12.2.e,14.12.2.e,14.12.2.e,14.12.2.e,13.11.2.e,,14.12.2.e,,
,14.14.1.,Number of sick SAM children admitted in standalone/ integrated NRC ,,13.12.1.,14.13.1.,14.13.1.,14.13.1.,14.13.1.,13.12.1.,,14.13.1.,,
,14.14.2.,Number of sick SAM children referred to standalone/ integrated NRC by Frontline Workers (AWW/ ASHA/ ANM) ,,13.12.2.,14.13.2.,14.13.2.,14.13.2.,14.13.2.,13.12.2.,,14.13.2.,,
,14.14.3.,Number of sick SAM children referred to standalone/ integrated NRC from IPD/OPD of other Health Facility (PHC/CHC/SDH/DH/other NRC) ,,13.12.3.,14.13.3.,14.13.3.,14.13.3.,14.13.3.,13.12.3.,,14.13.3.,,
,14.14.4.,Number of children Referred to standalone/ integrated NRC by RBSK Team ,,13.12.4.,14.13.4.,14.13.4.,14.13.4.,14.13.4.,13.12.4.,,14.13.4.,,
,14.14.5.,Number of SAM children discharged from standalone/ integrated NRC who met the discharge criteria ,,13.12.5.,14.13.5.,14.13.5.,14.13.5.,14.13.5.,13.12.5.,,14.13.5.,,
,14.14.6.,Number of admitted children left against medical advice (LAMA) / defaulter ,,13.12.6.,14.13.6.,14.13.6.,14.13.6.,14.13.6.,13.12.6.,,14.13.6.,,
,14.14.7.,Number of children died while admitted in standalone/ intergrated NRC ,,13.12.7.,14.13.7.,14.13.7.,14.13.7.,14.13.7.,13.12.7.,,14.13.7.,,
,14.14.8.,Number of children who completed all four post discharge follow-ups ,,13.12.8.,14.13.8.,14.13.8.,14.13.8.,14.13.8.,13.12.8.,,14.13.8.,,
,14.14.9.,Number of sick SAM children treated and admitted in the pediatric facility (other than standalone/ integrated NRC) ,,13.12.9.,14.13.9.,14.13.9.,14.13.9.,14.13.9.,13.12.9.,,14.13.9.,,
,14.14.10.,In-Patient Head Count at midnight for standalone/ integrated NRC ,,13.12.10.,14.13.10.,14.13.10.,14.13.10.,14.13.10.,13.12.10.,,14.13.10.,,
,14.15.1.,Number of Rogi Kalyan Samiti (RKS) meetings held ,,13.13.1.,14.14.,14.14.,14.14.,14.14.,13.13.1.,,14.14.,,
,14.15.2.,Number of Jan Arogya Samiti (JAS) meetings held ,12.8.,13.13.2.,,,,,13.13.2.,,,,
,14.16.,Number of Anganwadi centres reported to have conducted atleast one Village Health & Nutrition Day (VHNDs)/UHND/ Outreach / Special Outreach sessions ,12.9.,13.14.,14.15.,14.15.,14.15.,,13.14.,,14.15.,,
,14.17.,Total number of UHND/VHND sessions conducted in the reporting month ,12.10.,13.15.,14.16.,14.16.,14.16.,,13.15.,,14.16.,,
,14.18.,Total number of Outreach/Special Outreach camps conducted in the reporting month ,12.11.,13.16.,14.17.,14.17.,14.17.,,13.16.,,14.17.,,
,14.18.1.,Total number of outreach visits conducted by staff ,12.11.1.,13.16.1.,14.17.1.,14.17.1.,14.17.1.,,13.16.1.,,14.17.1.,,
,14.18.2.,Total number of outreach visits made by DMHP team ,,,,14.17.2.,14.17.2.,,,,14.17.2.,,
M14 [Patient Services],14.18.3,Total number of awareness campaigns/camps conducted for Mental Health ,12.11.2.,13.16.2. ,14.17.2. ,14.17.3.,14.17.3.,,13.16.2.,,14.17.3.,,
,14.19.,Patient Satisfaction Score of the facility in percentage (from Mera Aspatal) ,12.12.,13.17.,14.18.,14.18.,14.18.,,13.17.,,14.18.,,
,14.20.1.a,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis A (IgM Anti- HAV) ,,,,,14.19.1.a,,,,,,
,14.20.1.b,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis B i.e. HBsAg (excluding pregnant women) ,12.13.1.a,13.18.1.a,14.19.1.a,14.19.1.a,14.19.1.b,,13.18.1.a,,14.19.1.a,,
,14.20.1.c,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis C(Anti- HCV) ,12.13.1.b,13.18.1.b,14.19.1.b,14.19.1.b,14.19.1.c,,13.18.1.b,,14.19.1.b,,
,14.20.1.d,Total number of blood samples screened by ELISA/Rapid tests for viral hepatitis E(i.e. IgM Anti-HEV) ,,,,,14.19.1.d,,,,,,
,14.20.2.a,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis A (out of those tested for IgM Anti- HAV) ,,,,,14.19.2.a,,,,,,
,14.20.2.b,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis B (out of those tested for HBsAg excluding pregnant women) ,12.13.2.a,13.18.2.a,14.19.2.a,14.19.2.a,14.19.2.b,,13.18.2.a,,14.19.2.a,,
,14.20.2.b.i,Total number of positive blood samples for hepatitis B by ELISA/ Rapid tests tested for HBV DNA(out of those tested positive for HBsAg excluding pregnant women) ,,13.18.2.a.i,14.19.2.a.i,14.19.2.a.i,14.19.2.b.i,,13.18.2.a.i,,14.19.2.a.i,,
,14.20.2.b.ii,Total number of patients found positive for HBsAg eligible for treatment for hepatitis B (excluding pregnant women) ,,13.18.2.a.ii,14.19.2.a.ii,14.19.2.a.ii,14.19.2.b.ii,,13.18.2.a.ii,,14.19.2.a.ii,,
,14.20.2.b.iii,Total number of patients eligible for treatment for Hepatitis B put on treatment(out of those eligible for treatment excluding pregnant women) ,,13.18.2.a.iii,14.19.2.a.iii,14.19.2.a.iii,14.19.2.b.iii,,13.18.2.a.iii,,14.19.2.a.iii,,
,14.20.2.c,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis C (out of those tested for Anti-HCV) ,12.13.2.b,13.18.2.b,14.19.2.b,14.19.2.b,14.19.2.c,,13.18.2.b,,14.19.2.b,,
,14.20.2.c.i,Total number of positive blood samples for Hepatitis C screened by test (ELISA/ Rapid tests) confirmed by HCV RNA testing (out of those positive for anti-HCV) ,,13.18.2.b.i,14.19.2.b.i,14.19.2.b.i,14.19.2.c.i,,13.18.2.b.i,,14.19.2.b.i,,
,14.20.2.c.ii,Total number of patients put on treatment for Hepatitis C (out of those confirmed by HCV RNA i.e. HCV RNA detected) ,,13.18.2.b.ii,14.19.2.b.ii,14.19.2.b.ii,14.19.2.c.ii,,13.18.2.b.ii,,14.19.2.b.ii,,
,14.20.2.c.iii,Total number of positive Hepatitis C patients who have completed treatment ,,13.18.2.b.iii,14.19.2.b.iii,14.19.2.b.iii,14.19.2.c.iii,,13.18.2.b.iii,,14.19.2.b.iii,,
,14.20.2.c.iv,Total number of patients cleared for HCV RNA on sustained virological response at 12 weeks (SVR12) ,,13.18.2.b.iv,14.19.2.b.iv,14.19.2.b.iv,14.19.2.c.iv,,13.18.2.b.iv,,14.19.2.b.iv,,
,14.20.2.d,Total number of blood samples tested positive by ELISA/ Rapid tests for Hepatitis E(out of those tested for IgM Anti-HEV) ,,,,,14.19.2.d,,,,,,
,14.20.3.a,Number of Pregnant Women tested for HBsAg ,12.13.3.a,13.18.3.a,14.19.3.a,14.19.3.a,14.19.3.a,,13.18.3.a,,14.19.3.a,,
,14.20.3.b,Number of Pregnant Women who are HBsAg positive(out of those tested for Hepatitis B i.e. HBsAg) ,12.13.3.b,13.18.3.b,14.19.3.b,14.19.3.b,14.19.3.b,,13.18.3.b,7.5.1.a,14.19.3.b,,
M14 [Patient Services],14.20.3.c,Number of Pregnant Women found positive for HBsAg referred out to higher centre for institutional delivery ,12.13.3.c,13.18.3.c,14.19.3.c,14.19.3.c,14.19.3.c,,13.18.3.c,,14.19.3.c,,
,14.20.3.d,Number of Pregnant Women found positive for HBsAg delivered in an institution ,,13.18.3.d,14.19.3.d,14.19.3.d,14.19.3.d,,13.18.3.d,,14.19.3.d,,
,14.20.3.e,Number of newborn who received birth dose of Hepatitis B vaccine born to HBsAg positive pregnant women ,12.13.3.d,13.18.3.e,14.19.3.e,14.19.3.e,14.19.3.e,,13.18.3.e,,14.19.3.e,,
,14.20.3.f,Number of New Borns to Pregnant Women (found positive for HBsAg) received Hepatitis B Immunoglobulin (HBIG) (within 24 hours of birth) ,,13.18.3.f,14.19.3.f,14.19.3.f,14.19.3.f,,13.18.3.f,7.5.1.b,14.19.3.f,,
M15 [Laboratory Testing],15.1.1.,Total Number of Lab Tests done- Inhouse (including kits tests conducted in Laboratory) ,13.1.1.,14.1.1.,15.1.1.,15.1.1.,15.1.1.,,14.1.1.,8.1.1.,15.1.1.,,
,15.1.2.,Total Number of Lab Tests done- Outsourced (including kits tests conducted in Laboratory) ,13.1.2.,14.1.2.,15.1.2.,15.1.2.,15.1.2.,,14.1.2.,8.1.2.,15.1.2.,,
,15.1.3.,Total Number of Kit Tests conducted in Outreach areas/Camps/in-facility(outside lab) ,13.1.3.,14.1.3.,15.1.3.,15.1.3.,15.1.3.,,14.1.3.,,15.1.3.,,
,15.2.1.,Number of Hb tests conducted including kit tests ,13.2.1.,14.2.1,15.2.1.,15.2.1.,15.2.1.,,14.2.1,,15.2.1.,,
,15.2.2.,"Out of the total number of Hb tests done, Number having Hb < 7 mg ",13.2.2.,14.2.2,15.2.2.,15.2.2.,15.2.2.,,14.2.2,,15.2.2.,,
,15.3.1.a,Number of males screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,13.3.1.a,14.3.1.a,15.3.1.a,15.3.1.a,15.3.1.a,,14.3.1.a,,15.3.1.a,,
,15.3.1.b,"Out of the above, No. of males found reactive for HIV ",13.3.1.b,14.3.1.b,15.3.1.b,15.3.1.b,15.3.1.b,,14.3.1.b,,15.3.1.b,,
,15.3.1.c,No. of males subjected to HIV test at Confirmatory Centre/Stand Alone-ICTC ,13.3.1.c,14.3.1.c,15.3.1.c,15.3.1.c,15.3.1.c,,14.3.1.c,,15.3.1.c,,
,15.3.1.d,"Out of the above, No. of males confirmed as HIV Positive ",13.3.1.d,14.3.1.d,15.3.1.d,15.3.1.d,15.3.1.d,,14.3.1.d,,15.3.1.d,,
,15.3.2.a,Number of females (non-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,13.3.2.a,14.3.2.a,15.3.2.a,15.3.2.a,15.3.2.a,,14.3.2.a,,15.3.2.a,,
,15.3.2.b,"Out of the above, No. of females (non-ANC) found reactive for HIV ",13.3.2.b,14.3.2.b,15.3.2.b,15.3.2.b,15.3.2.b,,14.3.2.b,,15.3.2.b,,
,15.3.2.c,No. of females (non-ANC) subjected to HIV test at Confirmatory Centre/Stand Alone-ICTC ,13.3.2.c,14.3.2.c,15.3.2.c,15.3.2.c,15.3.2.c,,14.3.2.c,,15.3.2.c,,
,15.3.2.d,"Out of the above, No. of females (non-ANC) confirmed as HIV Positive ",13.3.2.d,14.3.2.d,15.3.2.d,15.3.2.d,15.3.2.d,,14.3.2.d,,15.3.2.d,,
,15.3.3.a,Number of Pregnant Women (PW-ANC) screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,13.3.3.a,14.3.3.a,15.3.3.a,15.3.3.a,15.3.3.a,,14.3.3.a,,15.3.3.a,,
,15.3.3.b,"Out of the above, No. of PW(ANC) found reactive for HIV ",13.3.3.b,14.3.3.b,15.3.3.b,15.3.3.b,15.3.3.b,,14.3.3.b,,15.3.3.b,,
,15.3.3.c,No. of PW(ANC) subjected to HIV test at Confirmatory Centre/Stand Alone-ICTC ,13.3.3.c,14.3.3.c,15.3.3.c,15.3.3.c,15.3.3.c,,14.3.3.c,,15.3.3.c,,
,15.3.3.d,"Out of the above, No. of PW(ANC) confirmed as HIV Positive ",13.3.3.d,14.3.3.d,15.3.3.d,15.3.3.d,15.3.3.d,,14.3.3.d,,15.3.3.d,,
,15.3.3.e,Number of DIL women screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,,14.3.3.e,15.3.3.e,15.3.3.e,15.3.3.e,,14.3.3.e,,15.3.3.e,,
,15.3.3.f,"Out of the above, No. of DIL women found reactive for HIV ",,14.3.3.f,15.3.3.f,15.3.3.f,15.3.3.f,,14.3.3.f,,15.3.3.f,,
,15.3.3.g,No. of DIL women subjected to HIV test at Confirmatory Centre/Stand Alone-ICTC ,,,,15.3.3.g,15.3.3.g,,,,15.3.3.g,,
M15 [Laboratory Testing],15.3.3.h,"Out of the above, No. of DIL women confirmed as HIV Positive ",,,,15.3.3.h,15.3.3.h,,,,15.3.3.h,,
,15.3.3.i,Number of Pregnant Women (ANC&DIL) screened for HIV more than once(Repeated testing) ,13.3.3.e,14.3.3.g,15.3.3.g,15.3.3.i,15.3.3.i,,14.3.3.g,,15.3.3.i,,
,15.3.4.a,Number of H/TG people screened for HIV by Whole Blood Finger Prick/RDT test/POC test ,13.3.4.a,14.3.4.a,15.3.4.a,15.3.4.a,15.3.4.a,,14.3.4.a,,15.3.4.a,,
,15.3.4.b,"Out of the above, No. of H/TG people found reactive for HIV ",13.3.4.b,14.3.4.b,15.3.4.b,15.3.4.b,15.3.4.b,,14.3.4.b,,15.3.4.b,,
,15.3.4.c,No. of H/TG people subjected to HIV test at Confirmatory Centre/Stand Alone-ICTC ,13.3.4.c,14.3.4.c,15.3.4.c,15.3.4.c,15.3.4.c,,14.3.4.c,,15.3.4.c,,
,15.3.4.d,"Out of the above, No. of H/TG people confirmed as HIV Positive ",13.3.4.d,14.3.4.d,15.3.4.d,15.3.4.d,15.3.4.d,,14.3.4.d,,15.3.4.d,,
,15.4.1.a,Total number of males tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,13.4.1.a,14.4.1.a,15.4.1.a,15.4.1.a,15.4.1.a,,14.4.1.a,,15.4.1.a,,
,15.4.1.b,"Out of the above, number of males tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",13.4.1.b,14.4.1.b,15.4.1.b,15.4.1.b,15.4.1.b,,14.4.1.b,,15.4.1.b,,
,15.4.1.c,"Out of the above, number of males treated for Syphilis ",13.4.1.c,14.4.1.c,15.4.1.c,15.4.1.c,15.4.1.c,,14.4.1.c,,15.4.1.c,,
,15.4.2.a,Total number of female (non-ANC) tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,13.4.2.a,14.4.2.a,15.4.2.a,15.4.2.a,15.4.2.a,,14.4.2.a,,15.4.2.a,,
,15.4.2.b,"Out of the above, number of females (non-ANC) tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",13.4.2.b,14.4.2.b,15.4.2.b,15.4.2.b,15.4.2.b,,14.4.2.b,,15.4.2.b,,
,15.4.2.c,"Out of the above, number of females (non-ANC) treated for Syphilis ",13.4.2.c,14.4.2.c,15.4.2.c,15.4.2.c,15.4.2.c,,14.4.2.c,,15.4.2.c,,
,15.4.3.a,Total number of H/TG people tested for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ,13.4.3.a,14.4.3.a,15.4.3.a,15.4.3.a,15.4.3.a,,14.4.3.a,,15.4.3.a,,
,15.4.3.b,"Out of the above, number of H/TG people tested reactive for Syphilis (RPR/VDRL/PoC/ RDT/TPHA) ",13.4.3.b,14.4.3.b,15.4.3.b,15.4.3.b,15.4.3.b,,14.4.3.b,,15.4.3.b,,
,15.4.3.c,"Out of the above, number of H/TG people treated for Syphilis ",13.4.3.c,14.4.3.c,15.4.3.c,15.4.3.c,15.4.3.c,,14.4.3.c,,15.4.3.c,,
,15.5.1,Widal tests- Number Tested ,,14.5.1.,15.5.1.,15.5.1.,15.5.1.,,14.5.1.,,15.5.1.,,
,15.5.2,Widal tests- Number Positive ,,14.5.2.,15.5.2.,15.5.2.,15.5.2.,,14.5.2.,,15.5.2.,,
,15.6.1.a.i,X-ray(Inhouse) ,,14.6.1.a.i,15.6.1.a.i,15.6.1.a.i,15.6.1.a.i,,14.6.1.a.i,8.2.1.a,15.6.1.a.i,,
,15.6.1.a.i.1,"X-ray(Inhouse)-No. of chest X-rays done on patients with health risks- Diabetes, HIV, Smoking, Alcoholism, low BMI, geriatric population (>60),history of TB, contacts of TB ",,14.6.1.a.i.1 ,15.6.1.a.i.1 ,15.6.1.a.i.1 ,15.6.1.a.i.1 ,,14.6.1.a.i.1,8.2.1.a.i,15.6.1.a.i.1 ,,
,15.6.1.a.ii,X-ray(Outsource) ,,14.6.1.a.ii,15.6.1.a.ii,15.6.1.a.ii,15.6.1.a.ii,,14.6.1.a.ii,,15.6.1.a.ii,,
,15.6.1.b.i,Ultrasonography (USG) (Inhouse) ,,14.6.1.b.i,15.6.1.b.i,15.6.1.b.i,15.6.1.b.i,,14.6.1.b.i,8.2.1.b,15.6.1.b.i,,
,15.6.1.b.ii,Ultrasonography (USG)(Outsource) ,,14.6.1.b.ii,15.6.1.b.ii,15.6.1.b.ii,15.6.1.b.ii,,14.6.1.b.ii,,15.6.1.b.ii,,
,15.6.1.c.i,CT scan (Inhouse) ,,,,15.6.1.c.i,15.6.1.c.i,,,8.2.1.c,15.6.1.c.i,,
,15.6.1.c.ii,CT scan (Outsource) ,,,,15.6.1.c.ii,15.6.1.c.ii,,,,15.6.1.c.ii,,
,15.6.1.d.i,MRI (Inhouse) ,,,,15.6.1.d.i,15.6.1.d.i,,,8.2.1.d,15.6.1.d.i,,
,15.6.1.d.ii,MRI (Outsource) ,,,,15.6.1.d.ii,15.6.1.d.ii,,,,15.6.1.d.ii,,
,15.6.1.e.i,ECG (Inhouse) ,,14.6.1.c.i,15.6.1.c.i,15.6.1.e.i,15.6.1.e.i,,14.6.1.c.i,8.2.1.e,15.6.1.e.i,,
,15.6.1.e.ii,ECG (Outsource) ,,14.6.1.c.ii,15.6.1.c.ii,15.6.1.e.ii,15.6.1.e.ii,,14.6.1.c.ii,,15.6.1.e.ii,,
M16 [Details of deaths reported],16.1.1a,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth at Facility/Facility to facility in transit ,14.1.1.a,15.1.1.a,16.1.1.a,16.1.1.a,16.1.1.a,,15.1.1.a,9.1.1.,16.1.1.a,,
,16.1.1.b,New born deaths within 24 hrs(1 to 23 Hrs 59 minutes) of birth in Community (at home or home to facility transit) ,14.1.1.b,15.1.1.b,16.1.1.b,16.1.1.b,16.1.1.b,,15.1.1.b,,16.1.1.b,,
,16.1.2.a,New born deaths within 1 week (1 to 7 days) at Facility/Facility to facility in transit ,14.1.2.a,15.1.2.a,16.1.2.a,16.1.2.a,16.1.2.a,,15.1.2.a,9.1.2.,16.1.2.a,,
,16.1.2.b,New born deaths within 1 week (1 to 7 days) At Community (at home or home to facility transit) ,14.1.2.b,15.1.2.b,16.1.2.b,16.1.2.b,16.1.2.b,,15.1.2.b,,16.1.2.b,,
,16.1.3.a,New born deaths within 8 to 28 days at Facility/Facility to facility in transit ,14.1.3.a,15.1.3.a,16.1.3.a,16.1.3.a,16.1.3.a,,15.1.3.a,9.1.3.,16.1.3.a,,
,16.1.3.b,New born deaths within 8 to 28 days At Community (at home or home to facility transit) ,14.1.3.b,15.1.3.b,16.1.3.b,16.1.3.b,16.1.3.b,,15.1.3.b,,16.1.3.b,,
,16.1.4.a,Infant Deaths (>28 days to below 12 months) at Facility/Facility to facility in transit ,14.1.4.a,15.1.4.a,16.1.4.a,16.1.4.a,16.1.4.a,,15.1.4.a,9.1.4.,16.1.4.a,,
,16.1.4.b,Infant Deaths (>28 days to below 12 months) At Community (at home or home to facility transit) ,14.1.4.b,15.1.4.b,16.1.4.b,16.1.4.b,16.1.4.b,,15.1.4.b,,16.1.4.b,,
,16.2.1.,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Sepsis ,14.2.1.,15.2.1.,16.2.1.,16.2.1.,16.2.1.,,15.2.1.,9.2.1.,16.2.1.,,
,16.2.2.,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Asphyxia ,14.2.2.,15.2.2.,16.2.2.,16.2.2.,16.2.2.,,15.2.2.,9.2.2.,16.2.2.,,
,16.2.3.,Neonatal Deaths up to 4 weeks (0 to 28 days) due to complications of Prematurity ,14.2.3.,15.2.3.,16.2.3.,16.2.3.,16.2.3.,,15.2.3.,9.2.3.,16.2.3.,,
,16.2.4.,Neonatal Deaths up to 4 weeks (0 to 28 days) due to Other causes ,14.2.4.,15.2.4.,16.2.4.,16.2.4.,16.2.4.,,15.2.4.,9.2.4.,16.2.4.,,
,16.3.1.,Number of Infant Deaths (>28 days - below 12 months) due to Pneumonia ,14.3.1.,15.3.1.,16.3.1.,16.3.1.,16.3.1.,,15.3.1.,9.3.1.,16.3.1.,,
,16.3.2.,Number of Infant Deaths (>28 days - below 12 months) due to Diarrhoea ,14.3.2.,15.3.2.,16.3.2.,16.3.2.,16.3.2.,,15.3.2.,9.3.2.,16.3.2.,,
,16.3.3.,Number of Infant Deaths (>28 days - below 12 months) due to Fever related ,14.3.3.,15.3.3.,16.3.3.,16.3.3.,16.3.3.,,15.3.3.,9.3.3.,16.3.3.,,
,16.3.4.,Number of Infant Deaths (>28 days - below 12 months) due to Measles ,14.3.4.,15.3.4.,16.3.4.,16.3.4.,16.3.4.,,15.3.4.,9.3.4.,16.3.4.,,
,16.3.5.,Number of Infant Deaths (>28 days - below 12 months) due to Others ,14.3.5.,15.3.5.,16.3.5.,16.3.5.,16.3.5.,,15.3.5.,9.3.5.,16.3.5.,,
,16.4.1.,Number of Child Deaths (1 - below 5 years) due to Pneumonia ,14.4.1.,15.4.1.,16.4.1.,16.4.1.,16.4.1.,,15.4.1.,9.4.1.,16.4.1.,,
,16.4.2.,Number of Child Deaths (1 - below 5 years) due to Diarrhoea ,14.4.2.,15.4.2.,16.4.2.,16.4.2.,16.4.2.,,15.4.2.,9.4.2.,16.4.2.,,
,16.4.3.,Number of Child Deaths (1 - below 5 years) due to Fever related ,14.4.3.,15.4.3.,16.4.3.,16.4.3.,16.4.3.,,15.4.3.,9.4.3.,16.4.3.,,
,16.4.4.,Number of Child Deaths (1 - below 5 years) due to Measles ,14.4.4.,15.4.4.,16.4.4.,16.4.4.,16.4.4.,,15.4.4.,9.4.4.,16.4.4.,,
,16.4.5.,Number of Child Deaths (1 - below 5 years) due to Others ,14.4.5.,15.4.5.,16.4.5.,16.4.5.,16.4.5.,,15.4.5.,9.4.5.,16.4.5.,,
,16.5.1.,Number of Maternal Deaths at facility due to APH (Antepartum Haemmorhage) ,14.5.1.,15.5.1.,16.5.1.,16.5.1.,16.5.1.,,15.5.1.,9.5.1.,16.5.1.,,
,16.5.2.,Number of Maternal Deaths at facility due to PPH (Post-Partum Haemmorhage) ,14.5.2.,15.5.2.,16.5.2.,16.5.2.,16.5.2.,,15.5.2.,9.5.2.,16.5.2.,,
M16 [Details of deaths reported],16.5.3.,"Number of Maternal Deaths at facility due to Pregnancy related infection and sepsis, Fever ",14.5.3.,15.5.3.,16.5.3.,16.5.3.,16.5.3.,,15.5.3.,9.5.3.,16.5.3.,,
,16.5.4.,Number of Maternal Deaths at facility due to Abortion and/ or its complication ,14.5.4.,15.5.4.,16.5.4.,16.5.4.,16.5.4.,,15.5.4.,9.5.4.,16.5.4.,,
,16.5.5.,Number of Maternal Deaths at facility due to Obstructed/prolonged labour ,14.5.5.,15.5.5.,16.5.5.,16.5.5.,16.5.5.,,15.5.5.,9.5.5.,16.5.5.,,
,16.5.6.,"Number of Maternal Deaths at facility due to Severe hypertension/fits/Pre Eclampsia/Eclampsia in pregnancy, during delivery and puerperium ",14.5.6.,15.5.6.,16.5.6.,16.5.6.,16.5.6.,,15.5.6.,9.5.6.,16.5.6.,,
,16.5.7.,Number of Maternal Deaths at facility due to Other/Unknown Causes ,14.5.7.,15.5.7.,16.5.7.,16.5.7.,16.5.7.,,15.5.7.,9.5.7.,16.5.7.,,
,16.5.8.,"Age wise total Maternal Deaths, occurred at Facility ",14.5.8.,15.5.8.,16.5.8.,16.5.8.,16.5.8.,,15.5.8.,9.5.8.,16.5.8.,,
,16.5.8.a,"Out of total number of maternal deaths at facility, deaths with age less than <15 years ",14.5.8.a,15.5.8.a,16.5.8.a,16.5.8.a,16.5.8.a,,15.5.8.a,9.5.8.a,16.5.8.a,,
,16.5.8.b,"Out of total number of maternal deaths at facility, deaths with age 15-19 years ",14.5.8.b,15.5.8.b,16.5.8.b,16.5.8.b,16.5.8.b,,15.5.8.b,9.5.8.b,16.5.8.b,,
,16.5.8.c,"Out of total number maternal deaths at facility, deaths with age more than >19-49 years ",14.5.8.c,15.5.8.c,16.5.8.c,16.5.8.c,16.5.8.c,,15.5.8.c,9.5.8.c,16.5.8.c,,
,16.5.8.d,"Out of total number maternal deaths at facility, deaths with age more than >49 years ",14.5.8.d,15.5.8.d,16.5.8.d,16.5.8.d,16.5.8.d,,15.5.8.d,9.5.8.d,16.5.8.d,,
,16.5.9.,"Total Maternal Deaths, occurred at Home to be reported at Block level",,,,,,,,,,3.1.1.,
,16.5.10.,Maternal Death in transit to be reported at Block level,,,,,,,,,,3.1.2.,
,16.5.11.a,"Out of total number of maternal deaths (Home & Transit deaths), deaths with age less than <15 years",,,,,,,,,,3.2.1.,
,16.5.11.b,"Out of total number of maternal deaths (Home & Transit deaths), deaths with age 15-19 years",,,,,,,,,,3.2.2.,
,16.5.11.c,"Out of total number maternal deaths (Home & Transit deaths), deaths with age more than >19-49 years",,,,,,,,,,3.2.3.,
,16.5.11.d,"Out of total number maternal deaths (Home & Transit deaths), deaths with age more than >49 years",,,,,,,,,,3.2.4.,
,16.5.12.a,Number of Maternal Deaths (Home & Transit deaths) due to APH (Antepartum Haemmorhage),,,,,,,,,,3.3.1.,
,16.5.12.b,Number of Maternal Deaths (Home & Transit deaths) due to PPH (Post-Partum Haemmorhage),,,,,,,,,,3.3.2.,
,16.5.12.c,"Number of Maternal Deaths (Home & Transit deaths) due to Pregnancy related infection and sepsis, Fever",,,,,,,,,,3.3.3.,
,16.5.12.d,Number of Maternal Deaths (Home & Transit deaths) due to abortion and/ or its complication,,,,,,,,,,3.3.4.,
,16.5.12.e,Number of Maternal Deaths (Home & Transit deaths) due to Obstructed/prolonged labour,,,,,,,,,,3.3.5.,
M16 [Details of deaths reported],16.5.12.f,"Number of Maternal Deaths (Home & Transit deaths) due to Severe hypertension/fits/Pre Eclampsia/Eclampsia & in pregnancy, during delivery and puerperium",,,,,,,,,,3.3.6.,
,16.5.12.g,Number of Maternal Deaths (Home & Transit deaths) due to Other/Unknown Causes,,,,,,,,,,3.3.7.,
,16.6.,Total Facility Based Maternal Death Reviews (FBMDR) done,,,16.6.,16.6.,16.6.,,,9.6.,16.6.,,
,16.7.1.,Number of deaths due to Diarrhoeal diseases ,14.6.1.,15.6.1.,16.7.1.,16.7.1.,16.7.1.,,15.6.1.,,16.7.1.,,
,16.7.2.,Number of deaths due to Tuberculosis ,14.6.2.,15.6.2.,16.7.2.,16.7.2.,16.7.2.,,15.6.2.,,16.7.2.,,
,16.7.3.,Number of deaths due to Respiratory diseases including infections (other than TB) ,14.6.3.,15.6.3.,16.7.3.,16.7.3.,16.7.3.,,15.6.3.,,16.7.3.,,
,16.7.4.,Number of deaths due to Other Fever Related ,14.6.4.,15.6.4.,16.7.4.,16.7.4.,16.7.4.,,15.6.4.,,16.7.4.,,
,16.7.5.,Number of deaths due to Heart disease/Hypertension related ,14.6.5.,15.6.5.,16.7.5.,16.7.5.,16.7.5.,,15.6.5.,,16.7.5.,,
,16.7.6.,Number of deaths due to Cancer ,14.6.6.,15.6.6.,16.7.6.,16.7.6.,16.7.6.,,15.6.6.,,16.7.6.,,
,16.7.7.,Number of deaths due to Neurological disease including strokes ,14.6.7.,15.6.7.,16.7.7.,16.7.7.,16.7.7.,,15.6.7.,,16.7.7.,,
,16.7.8.,Number of deaths due to Accidents/Burn cases ,14.6.8.,15.6.8.,16.7.8.,16.7.8.,16.7.8.,,15.6.8.,,16.7.8.,,
,16.7.9.,Number of deaths due to Animal bites and stings ,14.6.9.,15.6.9.,16.7.9.,16.7.9.,16.7.9.,,15.6.9.,,16.7.9.,,
,16.7.10.,Number of deaths due to Known Acute Disease ,14.6.10.,15.6.10.,16.7.10.,16.7.10.,16.7.10.,,15.6.10.,,16.7.10.,,
,16.7.11.,Number of deaths due to Known Chronic Disease ,14.6.11.,15.6.11.,16.7.11.,16.7.11.,16.7.11.,,15.6.11.,,16.7.11.,,
,16.7.12.,Number of deaths due to Other Causes ,14.6.12.,15.6.12.,16.7.12.,16.7.12.,16.7.12.,,15.6.12.,,16.7.12.,,
,16.8.1.,Number of Deaths due to Malaria- Plasmodium Vivax ,14.7.1.,15.7.1.,16.8.1.,16.8.1.,16.8.1.,,15.7.1.,,16.8.1.,,
,16.8.2.,Number of Deaths due to Malaria- Plasmodium Falciparum ,14.7.2.,15.7.2.,16.8.2.,16.8.2.,16.8.2.,,15.7.2.,,16.8.2.,,
,16.8.3.,Number of Deaths due to Kala Azar ,,15.7.3.,16.8.3.,16.8.3.,16.8.3.,,15.7.3.,,16.8.3.,,
,16.8.4.,Number of Deaths due to Dengue ,,15.7.4.,16.8.4.,16.8.4.,16.8.4.,,15.7.4.,,16.8.4.,,
,16.8.5.,Number of Deaths due to Acute Encephelitis Syndrome (AES) ,,15.7.5.,16.8.5.,16.8.5.,16.8.5.,,15.7.5.,,16.8.5.,,
,16.8.6.,Number of Deaths due to Japanese Encephalitis (JE) ,,15.7.6.,16.8.6.,16.8.6.,16.8.6.,,15.7.6.,,16.8.6.,,
,16.9.,Total Deaths (5 years and above of age): Excluding in-transit & maternal deaths ,14.8.,15.8.,16.9.,16.9.,16.9.,,15.8.,9.7.,16.9.,,
,16.9.1.,5 years and above to below 10 years ,14.8.1.,15.8.1.,16.9.1.,16.9.1,16.9.1.,,15.8.1.,9.7.1,16.9.1,,
,16.9.2.,10 year and above to below 19 years ,14.8.2.,15.8.2.,16.9.2.,16.9.2,16.9.2.,,15.8.2.,9.7.2,16.9.2,,
,16.9.3.,Adult 19 years and above ,14.8.3.,15.8.3.,16.9.3.,16.9.3,16.9.3.,,15.8.3.,9.7.3,16.9.3,,
,16.10.1.,In-transit Deaths: 1 year and below 5 years ,14.9.1.,15.9.1.,16.10.1,16.10.1,16.10.1,,15.9.1.,,16.10.1,,
,16.10.2.,In-transit Deaths: 5 years and above to below 10 years ,14.9.2.,15.9.2.,16.10.2,16.10.2,16.10.2,,15.9.2.,,16.10.2,,
,16.10.3.,In-transit Deaths: 10 year and above to below 19 years ,14.9.3.,15.9.3.,16.10.3,16.10.3,16.10.3,,15.9.3.,,16.10.3,,
,16.10.4.,In-transit Deaths: Adult 19 years and above ,14.9.4.,15.9.4.,16.10.4,16.10.4,16.10.4,,15.9.4.,,16.10.4,,
M17 [QA & BEMMP],17.1.1.,Total number of Haematology tests registered under External Quality Assurance Scheme (EQAS) ,,16.1.1.,17.1.1.,17.1.1.,17.1.1.,,16.1.1.,,17.1.1.,,
,17.1.2.,No. of registered Haematology tests reported EQAS Compliant ,,16.1.2.,17.1.2.,17.1.2.,17.1.2.,,16.1.2.,,17.1.2.,,
M17 [QA & BEMMP],17.1.3.,Total number of Biochemistry tests registered under External Quality Assurance Scheme (EQAS) ,,16.1.3.,17.1.3.,17.1.3.,17.1.3.,,16.1.3.,,17.1.3.,,
,17.1.4.,No. of registered Bio chemistry tests report EQAS Compliant ,,16.1.4.,17.1.4.,17.1.4.,17.1.4.,,16.1.4.,,17.1.4.,,
,17.1.5.,"Total Quantity of Bio medical waste generated in Kg for the month - (All Yellow, Red, white & Blue) ",15.1.1.,16.1.5.,17.1.5.,17.1.5.,17.1.5.,,16.1.5.,,17.1.5.,,
,17.1.6.,Total Quantity of General waste generated in Kg for the month ,15.1.2.,16.1.6.,17.1.6.,17.1.6.,17.1.6.,,16.1.6.,,17.1.6.,,
,17.2.1.,Total number of breakdown calls reported for the month ,,16.2.1.,17.2.1.,17.2.1.,17.2.1.,,16.2.1.,,17.2.1.,,
,17.2.2.,Total number of breakdown attended for the month ,,16.2.2.,17.2.2.,17.2.2.,17.2.2.,,16.2.2.,,17.2.2.,,
,17.2.3.,Number of visit made by the service engineer/ BME for the month ,,16.2.3.,17.2.3.,17.2.3.,17.2.3.,,16.2.3.,,17.2.3.,,
M19 [Death Reviews (DR) Done],19.1.,"Total Maternal Deaths Reviewed (MDR) by CMO, out of total reported maternal deaths",,,,,,,,,,,2.1.
,19.2.,"Total Maternal Deaths Reviewed (MDR) by DM, out of total reported maternal deaths",,,,,,,,,,,2.2.
,19.3.,Number of Maternal Deaths reviewed through Community based Maternal Death Review (CBMDR),,,,,,,,,,,2.3.
,19.4.,Total number of Child Deaths Reviewed by CMHO Level,,,,,,,,,,,2.4.
,19.5.,Total number of Child Deaths Reviewed by DM Level,,,,,,,,,,,2.5.
M20 [National Ambulance Services ],20.1.,Average response time (call to scene) for all BLS Ambulances in the district during the month,,,,,,,,,,,3.1.
,20.2.,Average response time (call to scene) for all ALS Ambulances in the district during the month,,,,,,,,,,,3.2.
,20.3.,Average number of trips per day by all ALS Ambulances in the district during the month,,,,,,,,,,,3.3.
,20.4.,Average number of trips per day by all BLS Ambulances in the district during the month,,,,,,,,,,,3.4.
,20.5.,Average kilometres travelled by all ALS Ambulances in the district during the month,,,,,,,,,,,3.5.
,20.6.,Average kilometres travelled by all BLS Ambulances in the district during the month,,,,,,,,,,,3.6.
M21 [National Leprosy Eradication Programme (NLEP)],21.1.,No. of new leprosy cases found during monthly survey,,,,,,,,,,,4.1.
,21.2.,No. of Childhood Leprosy cases (1-14) reported in a month,,,,,,,,,,,4.2.
,21.3.,No. of new Leprosy cases with Grade 2 disability reported in a month,,,,,,,,,,,4.3.
,21.4.,No. of leprosy patients undergone Reconstructive Surgery in a month,,,,,,,,,,,4.4.
M22 [National Oral Health Programme (NOHP)],21.5.1.,Total number of oral health camps organized at community/village level,,,,,,,,,,,5.1.
,21.5.1.a.,Number of oral health camps ONLY for screening organized at community/village level,,,,,,,,,,,5.2.
,21.5.1.b.,Number of oral health camps ONLY for treatment organized at community/village level,,,,,,,,,,,5.3.
M22 [National Oral Health Programme (NOHP)],21.5.2.,Total Number of oral health camps organized at school level for school children,,,,,,,,,,,5.4.
,21.5.2.a,Number of oral health camps ONLY for screening organized at school level for school children,,,,,,,,,,,5.5.
,21.5.2.b,Number of oral health camps ONLY for treatment organized at school level for school children,,,,,,,,,,,5.6.
M18 [Stock Position (During the Month)],18.1.,IFA tablets (Red) ,1. Balance From Previous Month,,,,,,,,,,1.1
,,,2. Stocks Received,,,,,,,,,,
,,,3. Unusable Stock,,,,,,,,,,
,,,4. Stock Distributed,,,,,,,,,,
,,,5. Total Stock,,,,,,,,,,
,18.2.,IFA - Blue (Adolescent 10-19 yrs) ,1. Balance From Previous Month,,,,,,,,,,1.2
,,,2. Stocks Received,,,,,,,,,,
,,,3. Unusable Stock,,,,,,,,,,
,,,4. Stock Distributed,,,,,,,,,,
,,,5. Total Stock,,,,,,,,,,
,18.3.,IFA- Pink (Junior 5-9 yrs) ,1. Balance From Previous Month,,,,,,,,,,1.3
,,,2. Stocks Received,,,,,,,,,,
,,,3. Unusable Stock,,,,,,,,,,
,,,4. Stock Distributed,,,,,,,,,,
,,,5. Total Stock,,,,,,,,,,
,18.4.,IFA Syrup (Paediatric) ,1. Balance From Previous Month,,,,,,,,,,1.4
,,,2. Stocks Received,,,,,,,,,,
,,,3. Unusable Stock,,,,,,,,,,
,,,4. Stock Distributed,,,,,,,,,,
,,,5. Total Stock,,,,,,,,,,
,18.5.,RTI /STI colour coded syndromic kits ( I to VII) ,1. Balance From Previous Month,,,,,,,,,,1.5
,,,2. Stocks Received,,,,,,,,,,
,,,3. Unusable Stock,,,,,,,,,,
,,,4. Stock Distributed,,,,,,,,,,
,,,5. Total Stock,,,,,,,,,,
,18.6.,Albendazole 400 mg tablets ,1. Balance From Previous Month,,,,,,,,,,1.6
,,,2. Stocks Received,,,,,,,,,,
,,,3. Unusable Stock,,,,,,,,,,
,,,4. Stock Distributed,,,,,,,,,,
,,,5. Total Stock,,,,,,,,,,